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ABSTRACT 
Inclusion body hepatitis (IBH) has been occurring as an economically important, 
emerging disease of broiler chickens in several countries. Historically, IBH has been identified 
as a secondary disease, often associated with common immunosuppressive diseases. However, 
few studies have identified IBH as a primary disease with no apparent association with 
immunosuppressive diseases. The objectives of this study were to develop an animal model of 
IBH in commercial broilers, to demonstrate vertical transmission of fowl adenoviruses (FAdVs) 
in broiler breeders and to control IBH in broilers by vaccinating their parents with an inactivated 
FAdV vaccine.  In order to develop an animal model of IBH in commercial broilers, fourteen-
day old broilers were inoculated intramuscularly with 1x104 – 1x107 CCID50 of either FAdV 
x11a-like virus, two strains of FAdV-8a (FAdV-8a strain TR-59 and FAdV-8a strain T8-A) or 
FAdV-11strain 1047. Four days following FAdV inoculation, 5% - 15% mortality was observed 
and dead birds showed histologic lesions of hemorrhagic necrotizing hepatitis. This animal 
model reproduced the clinical disease, and pathological lesions of IBH that have been described 
in commercial broilers. In order to demonstrate vertical transmission of the FAdV, 35-week-old 
broiler breeders were inoculated with 1x106 CCID50 of either FAdV x11a-like virus, FAdV-8a 
strain TR-59, FAdV-8a strain T8-A or FAdV-11 strain 1047. Eggs from infected breeders were 
collected and hatched seven days post-inoculation. Clinical signs or mortality were not observed 
in parents; however broiler progeny derived from broiler breeders inoculated with FAdV-8a 
strain T8-A had 30% IBH mortality by seven days of age. The hexon gene loop 1 sequence of 
the virus isolated from affected broiler progeny showed  100% identity to FAdV-8a strain T8-A. 
In order to demonstrate protection of broilers against IBH by vaccination of their parents, four  
groups of broiler breeders were vaccinated  with either FAdV-8a strain T8-A (2x107 or 2x104 
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CCID50) formulated with 20% oil-in-water emulsion, or FAdV x11a-like virus (2x107 or 2x104 
CCID50) formulated with 20% oil-in-water emulsion at the age of 12 and 15 weeks. The control 
group was inoculated with 20% oil-in-water emulsion. Broiler progeny were challenged with 
FAdV-8a strain T8-A to study the immunoprotective effect of the vaccine. Although, survival of 
broilers following FAdV-8a strain T8-A challenge was not significantly different among 
vaccinated and non-vaccinated groups (P>0.05), immunoprotective effect was enhanced by the 
increase dose of FAdV antigens (P>0.05). Further studies are necessary to improve the vaccine 
efficacy to protect broilers against IBH.  
In conclusion, the results of this study support the hypothesis that IBH in broilers in 
Canada is a vertically-transmitted primary disease with no known immunosuppressive 
involvement. The results also demonstrated that inactivated antigens of FAdV are able to 
partially protect broilers against IBH by vaccinating their parents. Further studies with different 
formulations, and priming the immune system of broiler breeders with live FAdV prior to 
vaccination with inactivated FAdV vaccines are necessary to improve the efficacy of inactivated 
IBH vaccine.     
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INTRODUCTION 
Inclusion body hepatitis (IBH) is an economically important, emerging problem in broiler 
chickens in several countries such as Australia, New Zealand, England, Germany, Japan, India, 
Italy, Canada, USA, Mexico and several Central and South American countries (Gomis et al., 
2006; Ojkic et al., 2008b). Historically, IBH has been identified as a secondary disease in broiler 
chickens associated with common immunosuppressive agents such as infectious bursal disease 
virus (IBDV) and chicken infectious anemia virus (CIAV) (Gomis et al., 2006). Pathogenesis of 
IBH is not clear due to multiple factors associated with its host, pathogen and the environment 
(Erny et al., 1991; Grimes, 1992; Mendelson et al., 1995; Gomis et al., 2006; Grimes, 2007). 
IBH was initially identified in broiler chickens with necrotizing hepatitis and intranuclear 
inclusion bodies (INIB) in the liver (Helmboltd and Fraizer, 1963), later,  a virus was identified 
as the etiological agent (Fadly and Winterfield, 1973). The causative agent was suspected to be 
an adenovirus (AdV) (Bickford et al., 1973; Antillon and Lucio, 1974). A similar disease 
identified as “inclusion body hepatitis” in broiler chickens was detected for the first time in 
Canada in 1970 (Howell et al., 1970). Presently, IBH is an important acute, viral infection of 
broiler chickens aged between 2 -7 weeks of age (Adair and Fitzgerald, 2008). Outbreaks of IBH 
in two-week old broiler breeder chickens (Grimes et al., 1977b; El-Attrache and Villegas, 2001; 
Philippe et al., 2007), and layer chickens (Winterfield et al., 1973; Hoffman et al., 1975) and a 
case of IBH in a rooster from a specific-pathogen-free (SPF) flock have been reported (Reece et 
al., 1986b).  
The disease is manifested as sudden onset of increased mortality of 1 – 10% (Gomis et 
al., 2006), and occasionally exceeding 30 - 40% (Barr and Scott, 1988; Erny et al., 1991), with a 
short clinical course of 4 – 5 days. The affected chickens typically have pale, friable, swollen 
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livers with focal to extensive necrosis, and large basophilic INIB in hepatocytes (Reece et al., 
1986a). Since the initial studies, IBH has been reported in North America (El-Attrache and 
Villegas, 2001; Gomis et al., 2006; Alvarado et al., 2007; Ojkic et al., 2008b), Mexico (Antillon 
and Lucio, 1974; Sarfati, 1991), Europe (Young et al., 1972; Hoffman et al., 1975), Japan 
(Itakura et al., 1974b; Otsuki et al., 1976), New Zealand (Christensen and Saifuddin, 1989), 
Australia (Wells et al., 1977; Reece et al., 1986a; Grimes, 1992), and several Latin American 
countries (Toro et al., 1999). Control of IBH has been attempted in several countries by 
vaccination of boiler breeders and broilers with inactivated, autogenous vaccines (Cowen, 1992; 
Alvarado et al., 2007).  
A FAdV-5, Tipton strain was incriminated in the etiology of IBH (Bickford, 1972; Fadly 
and Winterfield, 1973; Rosenberger et al., 1974; McFerran et al., 1976b). Thereafter, all other 
serotypes of FAdV have been associated with outbreaks of IBH in chickens: FAdV-1 (Singh et 
al., 1996); FAdV-2 (Philippe et al., 2005); FAdV-3 and FAdV-4 (Grimes and King, 1977a); 
(McFerran et al., 1976b); FAdV-4 (Mazaheri et al., 1998); FAdV-6, FAdV-7, FAdV-8, FAdV-
8a, FAdV-8b and FAdV-11 (Grimes et al., 1977b; Kefford and Borland, 1979; Ojkic et al., 2005; 
Ojkic et al., 2008a); FAdV-9 (Grimes et al., 1978b); FAdV-7 and FAdV-10 (Barr and Scott, 
1988); FAdV-11 (Mendelson et al., 1995) and FAdV-12 (Saifuddin et al., 1992). The disease has 
been experimentally reproduced in broiler chickens with isolates from IBH outbreaks (Fadly and 
Winterfield, 1973; Wells and Harrigan, 1974).  
Identification of IBH as a primary disease in broilers has urged vaccination as a strategy 
to control IBH at their parent level (Grimes, 1992; Ahmad and Burgess, 2001; Sanei, 2009). 
Control of IBH has been attempted in several countries by vaccination of broiler breeders and 
broiler chickens with inactivated, autogenous (Lohmann Animal Health International, 
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Waterville, ME) (Cowen, 1992; Alvarado et al., 2007) or chick-embryo propagated vaccines 
(Engormix, Mexico). In Australia, IBH is successfully controlled by vaccination of broiler 
breeders with a commercial live, chick embryo liver cell-grown vaccine containing FAdV-8b 
strain (Intervet Australia, Pvt. Ltd.). Further, this vaccine was recommended to be administered 
by the eye-drop method in pullets at the age of 12 to 16 weeks (Grimes, 1992; 2007).  
Another disease syndrome related to IBH,  hydropericardium syndrome/inclusion body 
hepatitis (HPS/IBH) is an emerging, economically important disease typically infecting 3 – 6 
week old broiler chicken caused by FAdV-4 (Balamurugan and Kataria, 2004). Control of 
HPS/IBH has also been attempted through vaccination of broiler breeders or broiler chickens 
with autogenous vaccines containing inactivated FAdV-4 (Chishti et al., 1989; Ahmad et al., 
1990; Shane and Jaffrey, 1997).  
Since 2000, IBH has been responsible for severe economic losses in the Canadian broiler 
industry due to sudden onset of increased mortality lasting for 5- 7 days (Gomis et al., 2006; 
Ojkic et al., 2008b). Although high mortality and economic losses continued for several years in 
the Canadian broiler industry due to IBH, no commercial vaccines are available to-date, except 
limited application of autogenous vaccines (Ojkic et al., 2008a; Sanei, 2009). The objectives of 
this research project were:  (a) to develop an animal model of IBH in commercial broilers; (b) to 
demonstrate vertical transmission of FAdV in broiler breeders to their progeny; (c) and to control 
IBH in broiler chickens by vaccinating their parents with an inactivated FAdV vaccine.  
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1.0. LITERATURE REVIEW 
The purpose of this review is to provide general information about fowl adenoviruses 
(FAdVs), and in particular, etiology, pathogenesis and control strategies pertaining to inclusion 
body hepatitis (IBH) in broiler chickens.  
  
 1.1. General properties of adenoviruses   
Adenoviruses (AdVs) are common infectious agents in humans, poultry, and wildlife 
worldwide (Russell, 2000; Fitzgerald, 2008). AdVs are able to infect a wide range of species or  
a variety of actively dividing as well as post-mitotic cells. However, those AdVs that produce 
disease cause lesions in a narrow range of organs (Russell, 2000). Generally, they exhibit a low 
level of virulence (Schrenzel et al., 2005). Most of the AdVs are species-specific (Wold and 
Horwitz, 2007), and the host range of any AdV is restricted to one or, at most, a few closely-
related species of animals (Sambrook et al., 1980). Most of the knowledge on adenoviral 
structure, biology, genomic organization and replication originates from studies done with 
human adenoviruses (HAdVs) (Benko et al., 2005). The HAdVs have been recognized as 
significant viral pathogens, with higher morbidity and mortality among immunocompromized 
people (Echavarria, 2008).  
The AdVs are lytic DNA viruses; however, many AdV replicate in the host with little or no 
apparent signs of disease (Adair and Fitzgerald, 2008). Generally, they are considered to be 
facultative or opportunistic pathogens. The presence of predisposing factors such as 
compromised immune status, concurrent infection, stress; and mixing of a carrier population 
with immunologically naïve human, livestock or poultry species is required for the development 
of severe or fatal disease (Fitzgerald, 2008). Pathology is caused by the process of virus 
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replication and lysis of susceptible cells (Adair and Fitzgerald, 2008). Adenoviral disease can 
seldom be reproduced in immunocompetent individuals (Reece et al., 1986a). 
An AdV was first isolated from a dog with infectious canine hepatitis (Rubarth, 1947), 
and the intranuclear inclusions detected in hepatocytes were thought to be due to a filterable 
agent (Cowdry and Scott, 1930). The first HAdV was accidentally isolated from human adenoids 
(Rowe et al., 1953) and later named as “adenovirus” (Enders et al., 1956).  The first avian AdV 
to be identified was from a respiratory disease outbreak in bobwhite quail (Colinus virginianus) 
(Olson, 1950). Since then, human, simian, bovine, murine, porcine, ovine and caprine AdVs 
have been extensively studied including aspects of virion properties and their function, virus-cell 
interactions, genomic organization, replication, models of cell-virus interactions and gene 
therapy vectors  (Benko et al., 2005; Wold and Horwitz, 2007).  
Adenoviruses are ubiquitous in poultry populations, as demonstrated by serological 
surveys (Cowen et al., 1977; Grimes et al., 1977a), and virus isolation  from normal and sick 
chickens of different ages (Yates and Rhee, 1975; Cowen et al., 1978b). They are readily 
isolated from intestinal tract of young and older chickens (McCracken and Adair, 1993). The 
first isolation and identification of an avian AdV as an infectious agent was carried out in 
chicken embryos (Yates and Fry, 1957). The majority of AdVs isolated from chicken embryos 
belonged to fowl adenovirus 2 (FAdV-2) and FAdV-5, however, attempts to isolate all FAdV 
have been successful (Cowen, 1988).  
 
1.2. Taxonomy and classification of adenoviruses  
Members of the family Adenoviridae are non-enveloped, 70-80 nm in diameter, single 
linear, double-stranded deoxyribonucleic acid (dsDNA) viruses which have a characteristic 
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icosahedral capsid of 240 non-vertex capsomeres (hexons), and 12 vertex capsomeres (pentons) 
each with one or two fibers protruding from the penton base (Russell, 2009) (Figures 1.1. A, B). 
Although all AdVs share a common structure, HAdV-40 and HAdV-41 (Russell and Benko, 
1999) and viruses of Aviadeniovirus (Adair and Fitzgerald, 2008) possess two fibers that project 
from the penton base of  (Gelderblom and Maichle-Lauppe, 1982). The size of the genome varies 
from 26 - 45 kbp with inverted terminal repeats linking the genome to the terminal protein at 
each end (Benko et al., 2005). Although structural differences among genera exists, the basic 
features of AdV are retained in all genera (Russell, 2009). The central part of the genome is well 
conserved throughout the family, while the two ends show a wide variation in length and content 
(Benko et al., 2005).  
The family Adenoviridae is designated by the International Committee on Taxonomy of 
Viruses (ICTV) to contain four genera: Mastadenovirus, Atadenovirus, Aviadenovirus, and 
Siadenovirus based on genomic organization, virion properties, structure, size and serological 
differences (Benko et al., 2005). A fifth, distinct genus containing fish and snake AdV has been 
proposed (Benko et al., 2002). The AdVs that infect birds have been classified using the highly 
conserved group-specific epitopes of the hexon protein (van Regenmortel et al., 1997), and 
designated  as group I, II or III avian adenovirus based on their common group antigen (Ag) 
(McFerran and Smyth, 2000; Fitzgerald, 2008; Pierson and Fitzgerald, 2008). Presently, the 
genera of the family Adenoviridae are classified as: Mastadenovirus mammalian AdV, 
Aviadenovirus  group I avian AdV, Siadenovirus group II avian AdV, and Atadenovirus group III 
avian AdV (Fitzgerald, 2008). However, they differ substantially at the molecular level 
(Fitzgerald, 2008). Although there is antigenic cross reactivity among members of each genus 
due to conserved epitopes on the hexon protein of AdV (Norrby et al., 1969), no known Ag that 
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is common to all AdVs has been detected (Wold and Horwitz, 2007). The differences among 
AdV serotypes of different animal species is determined by the hypervariable regions of the 
hexon protein as shown with HAdV (Crawford-Miksza and Schnurr, 1996). Within each species, 
genomes of the HAdV serotypes are highly related, and are modestly diverged (Wold and 
Horwitz, 2007). Certain viral proteins modify host immune response pathways which include 
inhibition of interferon function, inhibition of the intrinsic cellular apoptosis pathway and 
inhibition of major histocompatibility complex (MHC) class I in infected cells (Mahr and 
Gooding, 1999). As with HAdV, each serotype of FAdV has genetic variations that can be 
identified by DNA sequencing. The phylogenetic relationships of the hexon gene of identified 
AdV that infect vertebrates are shown in Figure 1.2. 
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Figure 1.1. Structure of fowl adenovirus. A) Negative-stained electron micrograph of FAdV, 
image from Sandoz GmbH, Holzkirchen, Germany. Inset: negative-stained electron micrograph 
of a FAdV from tissue culture lysate (uranyl acetate/lead citrate). B) Schematic diagram of AdV 
showing the main structural components. Adapted from Flint et al., 2009. 
  9 
 
Figure 1.2. Phylogenetic tree of the adenoviruses based on distance matrix analysis of hexon 
amino acid sequence. Abbreviated virus names are given at the end of the branches, and those 
belong to the same species are shaded. Species names listed to the right (recognized species in 
italics): B, ovine; C, canine; D, duck, E, equine; F, fowl; Fr, frog; H, human; M, murine; O, 
ovine; P, porcine; Po, possum; Sn, snake; T, turkey; TS, tree shrew. Adapted from Davison et al., 
2003.  
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 1.2.1. Mastadenovirus 
Mastadenovirus exclusively cause infections in mammals, including human, simian, bovine, 
canine, equine, ovine, porcine, murine and tree shrew (Benko et al., 2005). There are 51 human 
AdV (HAdV) serotypes classified in 6 species designated as A through F, that have been shown 
to cause a variety of acute respiratory and gastrointestinal tract infections, and conjunctivitis in 
children and military recruits (Albinana-Gimenez et al., 2009a). Some HAdV (Albinana-
Gimenez et al., 2009b) and some porcine AdV (Hundesa et al., 2006; Hundesa et al., 2009) have 
been suggested as potential microbial tracking tools for water contamination of  human and 
animal origin respectively.  
Following an infection, HAdV may be shed in feces for several months, and can be an 
endemic source to other individuals by fecal-oral route (Albinana-Gimenez et al., 2009a). These 
infections are self-limiting in the immunocompetent host. However, they cause severe, life-
threatening infections in immunocompromised individuals (Echavarria, 2008). Following an 
acute infection, they frequently establish a persistent low grade infection in tonsil and upper 
respiratory tract (Albinana-Gimenez et al., 2009a). 
 
 1.2.2. Siadenovirus  
Siadenovirus comprise frog adenovirus (FrAdV-1) and turkey adenovirus (TAdV-3) 
(Benko and Harrach, 2003). The FrAdV-1 is non-pathogenic while TAdV-3 is associated with 
specific diseases in different poultry species, i. e. hemorrhagic enteritis in turkeys, marble spleen 
disease in pheasants and avian adenovirus  splenomegaly in chickens (Benko and Harrach, 
2003).  
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1.2.2.1. Hemorrhagic enteritis  
Hemorrhagic enteritis (HE) was first reported in 1937 (Pomeroy and Fenstermacher, 
1937). It is an acute, viral disease of mostly 4 week and older turkeys (Pierson and Fitzgerald, 
2008). It is transmitted through oral or cloacal inoculation of infectious feces (Itakura et al., 
1974a). Contaminated litter acts as the main source of infection for subsequent flocks (Pierson 
and Fitzgerald, 2008). The spleen appears to be the main site of virus replication of hemorrhagic 
enteritis virus (HEV), as well as related marble spleen disease virus (MSDV) and, avian 
adenovirus and splenomegaly virus (AASV) with macrophages and B lymphocytes as the target 
cells (Suresh and Sharma, 1996). HEV and the other TAdV-3 diseases are characterized by 
depression, bloody droppings, immunosuppression, secondary bacterial infection and mortality 
varying from 1 – 80% with the average being 10 - 15% (Pierson and Fitzgerald, 2008). HEV is 
controlled in endemic areas by oral vaccination of 4 – 6 weeks old turkeys with crude spleen 
homogenates containing avirulent strains of HEV (Thorsen et al., 1982). 
 
1.2.2.2. Marble spleen disease   
Marble spleen disease (MSD) was first reported as an outbreak in ring-necked pheasants 
(Phasianus colchicus) (Mandelli et al., 1966). The causative agent, MSDV is antigenically 
similar to TAdV-1 and TAdV-2 (Iltis and Daniels, 1977). MDS has been documented in 
confinement pheasant operations in USA, Canada, Europe, Australia and Korea (Pierson and 
Fitzgerald, 2008). The disease occurs in 3 – 8 month old pheasants and the disease is 
characterized by lung edema, congestion, mottled (marbled) spleen and death. Experimental 
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reproduction of MDS has been successful with purified virus obtained from spleens of natural 
cases of pheasants and experimental cases of turkey affected with MSD (Iltis et al., 1975). 
 
1.2.2.3. Avian adenovirus splenomegaly 
Avian adenovirus splenomegaly (AAS) has been identified in 20 – 45 week old broiler 
breeders with clinical signs similar to those of MSD (Domermuth et al., 1979). In HE, MSD and 
AAS intranuclear inclusion bodies (INIB) are present in macrophages, lymphocytes, intestinal 
epithelium, spleen and a wide range of tissues (Pierson and Fitzgerald, 2008). Crude spleen 
homogenates containing avirulent isolates of HEV and MSDV or virus produced in cell culture 
have been used successfully to control HE and MSD (Domermuth et al., 1977; Fadly et al., 
1985).  
 
1.2.3. Atadenovirus 
Atadenoviruses have a broad host range, affecting snakes, lizards, ducks, geese, chickens, 
possums and ruminants (Benko et al., 2005). Egg drop syndrome virus (EDSV) was originally 
designated as the sole member of group III avian AdV (Adair and Symth, 2008), and later 
reclassified in  Atadenovirus (Benko et al., 2005).  
 
 1.2.3.1. Egg drop syndrome 
Egg drop syndrome (EDS) was first reported in 1976 (van Eck et al., 1976), and later, 
reported worldwide (Adair and Symth, 2008). Ducks and geese are probably the natural hosts of 
EDSV, which belongs to duck AdV-1 of the Atadenovirus. This virus was thought to be 
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introduced to chickens through vaccines prepared in duck embryos (Adair and Symth, 2008), and 
not by adaptation of EDSV in chickens (Tsukamoto et al., 2004). Infection causes outbreaks of 
EDS which is characterized by a sharp drop in egg production and various egg deformities (van 
Eck et al., 1976). EDSV replicates in the epithelial cells of the female reproductive tract (Adair 
and Symth, 2008), and often remains latent until chickens approach peak egg production with 
vertical transmission (McFerran et al., 1978). The outbreaks last for 4 – 10 weeks resulting in a 
40% reduction in egg production (Adair and Symth, 2008). Affected hens have regressive 
ovaries and atrophied oviducts. The INIB are found in surface epithelial cells of the pouch shell 
gland (Adair and Symth, 2008). Inactivated EDS vaccine given at 12- 16 weeks of age provides 
protection to hens throughout the laying period (Schijns et al., 2008). 
 
1.2.4. Aviadenovirus      
Aviadenovirus include group I avian AdV of chicken, turkey, duck and goose (Adair and 
Fitzgerald, 2008). A subgroup of Aviadenovirus, commonly referred to as fowl adenovirus 
(FAdV) consists of five species, designated as A-E based on restriction enzyme analysis (REA) 
of viral DNA (Zsak and Kisary, 1984). They are further delineated into 12 serotypes, FAdV-1 
through FAdV-11 with FAdV-8 subdivided into FAdV-8a and FAdV-8b, based on partial cross-
neutralization and phylogenetic difference of hexon protein L1 loop (Benko et al., 2005).  
Although the chicken embryo lethal orphan (CELO) virus is considered the type strain of 
FAdV-1 and typical of FAdV; hemagglutination of rat erythrocytes, abundant growth in 
embryonated  eggs (Adair and Fitzgerald, 2008) and oncogenic properties (McFerran, 1981a) 
which are not demonstrated by other FAdV, indicates the inappropriateness of considering it to 
be as the typical FAdV as any other FAdV does not generally posses any of such effects 
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(Gelderblom and Maichle-Lauppe, 1982; Erny et al., 1991; Pallister and Sheppard, 1996). 
Aviadenovirus are distinct from other genera by the presence of two fibers per vertex (Laver et 
al., 1971; Gelderblom and Maichle-Lauppe, 1982), and only infect birds (Benko et al., 2005).  
A FAdV serotype is defined as one which shows no cross-neutralization with others, or 
shows a homologous: heterologous titer ratio greater than 16 in both directions (Benko et al., 
2005). If the titer is between 8-16, serotypes can be differentiated by biophysical or biochemical 
methods (Erny et al., 1995; Hess et al., 1998). In the past, the American and European 
classification of FAdV have identified 12 serotypes designated as US/FAdV 1-12 and EU/FAdV 
1-12, respectively (McFerran, 1977). The Japanese (Kawamura et al., 1964) and the Hungarian 
(Khanna, 1964) classifications of FAdV have designated some strains into FAdV serotypes. The 
Canadian FAdV isolate showing identical homology of the hexon protein L1 loop sequence by 
phylogenetic analysis to FAdV-8a strain T8-A and FAdV-8b strain 764, distinguished by 
differences in the restriction fragment length polymorphism (RFLP) analysis (Meulemans et al., 
2001) and has been designated as FAdV-8a/8b Ontario strain (Ojkic et al., 2008b). Classification 
of 12 FAdV reference strains based on real-time polymerase chain reaction (PCR) and 
subsequent high-resolution melting point-curve analysis of three regions of the hexon gene has 
been developed (Steer et al., 2009).  
Classification of FAdV strains is based on cross-neutralization (Kawamura et al., 1964; 
McFerran et al., 1972; Calnek and Cowen, 1975; Grimes and King, 1977b), REA followed by 
pair-wise comparison of restriction fragment analysis (Mendelson et al., 1995; Pallister and 
Sheppard, 1996), or phylogenetic analysis of the hexon protein L1 loop which has the highest 
variability among the FAdV serotypes and form the type-specific epitopes (Toogood et al., 
1992). The fiber also has been shown to contain both type and subgroup-specific Ag (Norrby et 
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al., 1969). In these classifications, each serotype has a representative or type strain and several 
other strains with varying pathogenicity (Pallister et al., 1996). Strains of the same serotypes 
exhibit almost identical DNA restriction digestion patterns, whereas strains without cross 
reaction in neutralization tests show no common fragments (Monreal, 1992). Comparison of 
FAdV from different countries and continents has been difficult due to lack of agreement 
between serotypes, representative strains and different strains of each serotype (McFerran, 1997; 
Meulemans et al., 2004; Benko et al., 2005; Ojkic et al., 2008b; Steer et al., 2009). The 
classification of FAdV given in ICTV (Benko et al., 2005), and the American and European 
classifications (McFerran , 1997), with representative strains for each serotype, are summarized 
in Table 1.2. 
 The FAdVs share a common group Ag with viruses isolated from geese, ducks and 
turkeys (Adair and Fitzgerald, 2008), but demonstrate a broad antigenic variation causing a 
variety of diseases among diverse poultry species (Cowen et al., 1977; Hess, 2000; McFerran 
and Smyth, 2000). However, FAdVs propagate only in avian cells, preferably in homologous 
cells (Russell and Benko, 1999). Eventually, homologous cell cultures and cell lines of 
permissive cells superseded chick embryo due to adaptability, superior growth characteristics 
and versatility (Alexander et al., 1998; Adair and McFerran, 2008; Ojkic et al., 2008a). Most 
FAdV grow well in these cells with characteristic cytopathic effects (CPE) of cell rounding, 
refractility, and surface detachment (Adair and McFerran, 2008).  
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Table 1.1. Classification of avian adenoviruses. Serotype in bold; species names are in italic 
script; strain names in roman script.  
 1(Zsak and Kisary, 1984); 2(Benko et al., 2005); 3McFerran et al., 1977;  4(Meulemans et al., 2001) 5(Alvarado et al., 2007),  
6(Ojkic et al., 2008b); ?not available 
Fowl adenovirus 
species1 
ICTV FAdV  
serotype/strain2 
USA FAdV 
serotype/strain3 
Europe FAdV 
serotype/strain3 
Fowl adenovirus A FAdV-1  FAdV-1  FAdV-1 
  CELO, 112, Phelps       QBV, Indiana C,  
      T3, QT 
      CELO 
Fowl adenovirus B FAdV-5  FAdV-3  FAdV-5 
  340, TR-22       340-5, M2, IBH, 
      Tipton 
      
Fowl adenovirus C FAdV-4 
KR95, J2, KR5, J2A 
 FAdV-4  FAdV-4 
       506-1, HR-5      KR-5 
  FAdV-10  FAdV-10  FAdV-11 
  CFA20, C-2B, M11      C-2B  C-2B 
Fowl adenovirus D FAdV-2  FAdV-2  FAdV-2 
  P7-A, GAL-1, 685, Merlin      GAL-1A, P7, Z7, 
      SSR-48 
  GAL-1 
  FAdV-3    
  75, SR-49    
  FAdV-9  FAdV-9 (FAdV-8) 1  FAdV-10 
A-2A 
FAdV-12 
380 
  A2-A, 90  A2  
  FAdV-11  ?  
  380, 1047    
  FAdV-6  ?  FAdV-5 
CR119   CR119, 168   
Fowl adenovirus E FAdV-7  FAdV-10  FAdV-7 
  YR36, x-11, x11a4, x11a-like virus6      x-11  
 
x-11 
  FAdV-8a 
TR-59, T-8, CFA40, T8-A4 
 FAdV-5 
58-1, T-8, TR-59, U-
6, Q-1A 
 
 
FAdV-8 
TR-59 
  FAdV-8b   FAdV-7       FAdV-9 
  Stanford5, 764, B3 
 
      764, B3  764 
 
 
 
        
  FAdV-8a/8b     
  Ontario6   
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1.2.4.1. Quail bronchitis  
Quail bronchitis (QB) is a naturally occurring, acute, highly contagious, respiratory 
disease of 1 – 3 week old bobwhite quail (Colinus virginianus). It was first reported in 1950 as 
an outbreak in quail (Olsan, 1950), and later reported worldwide. QB mainly occurs in captive-
reared quail with a rapid onset of morbidity approaching 100% and mortality up to 50% 
characterized by ocular and nasal discharges, mucoid tracheitis and air sacculitis (Reed and Jack, 
2008). It is considered to be caused by quail bronchitis virus (QBV) or CELO virus of FAdV-1 
serotype (Reed and Jack, 2008). Histologically, extensive necrosis is present in the tracheal and 
bronchial epithelium, liver, spleen and bursa of Fabricius with large, basophilic INIB in these 
tissues but rarely in the spleen (Reed and Jack, 2008). Transmission of QB probably occurs by 
aerosol, and experimental infection in chickens or turkeys results in mild disease (Reed and Jack, 
2008). Serological evidence suggests unapparent infection of QB in chicken (Yates and Fry, 
1957). Prevention is based on protecting susceptible quail from all possible sources of QBV or 
CELO (Reed and Jack, 2008). 
 
1.2.4.2. Hydropericardium syndrome/inclusion body hepatitis  
Hydropericardium syndrome/inclusion body hepatitis (HPS/IBH) is an emerging, 
economically important disease of 3 – 6 week old broiler chickens (Balamurugan and Kataria, 
2004).  HPS/IBH has been occasionally reported in broiler breeder pullets aged between 2 - 32 
weeks (Asrani et al., 1997), and in pigeons (Naeem and Akram, 1995). The disease was first 
reported in 1987 (Anjum et al., 1989), and later  in India, Iraq, Russia, Japan, Mexico, and 
several Central and South American countries (Abdul-Aziz and Hasan, 1995; Hess et al., 1999; 
Ganesh and Raghavan, 2000). It is characterized by a sudden onset of mortality (20 - 80%), 
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hydropericardium and friable, swollen livers with necrosis (Balamurugan and Kataria, 2004). As 
HPS/IBH shares the liver lesions and presence of INIB in hepatocytes of broiler chickens with 
IBH, the disease is also called IBH/HPS, infectious hydropericardium, hydropericardium 
hepatitis syndrome or “Angara disease” (Adair and Fitzgerald, 2008). Severe hydropericardium 
and high mortality distinguishes IBH/HPS from IBH (Balamurugan and Kataria, 2004). 
Epidemiological investigations have shown FAdV- 4 as the causative agent (Voss et al., 1996; 
Mazaheri et al., 1998) with a genomic similarity of the viruses involved in HPS/IBH outbreaks 
in different geographical areas (Hess et al., 1999).  
The transmission of HPS/IBH occurs horizontally through contaminated feces and 
fomites; and the disease in progeny occurs through vertical transmission (Akhtar, 1994; 
Mazaheri et al., 2003; Balamurugan and Kataria, 2004). Several studies have been successful in 
experimental reproduction of HPS/IBH in broiler chickens (up to 3 weeks of age) by inoculation 
of liver homogenate (LH) of HPS/IBH from outbreaks (Anjum, 1990; Kumar et al., 1997; 
Ganesh, 1998) or purified virus prepared from field isolates (Ganesh et al., 2001a). Pathogenicity 
studies with HPS/IBH have suggested that a synergism with CIAV, or prior immunosuppression 
is required for experimental reproduction (Toro et al., 1999; Toro et al., 2000). An association 
with CIAV is also shown to be necessary for vertical transmission of FAdV associated with 
HPS/IBH (Toro et al., 2000), however, vertical transmission and occurrence of HPS/IBH in 
progeny has been demonstrated in SPF chickens (Mazaheri et al., 2003). Several studies have 
shown that flocks are protected with an autogenous, formalin-killed vaccine (Ganesh and 
Raghavan, 2000). It is possible to reproduce the disease in broiler chickens with liver 
homogenate from infected pigeons, and the disease in pigeons is controlled by a poultry vaccine 
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(Adair and Fitzgerald, 2008). Licensed killed vaccines are available for vaccination of broiler 
chickens against HPS/IBH (Zia et al., 2001). 
 
1.3. Morphology of fowl adenoviruses 
The icosahedral adenoviral capsid structure is composed of three major structural 
proteins: hexon, fiber, and penton (Crawford-Miksza and Schnurr, 1996) (Figure 1.1.B). The 
hexon is the most abundant structural protein on which group, type and subgroup specific 
antigenic determinants as well as neutralizing epitopes are located (Norrby et al., 1969; 
McFerran, 1981a; Russell, 2009). The hexon also has two functional components: the conserved 
pedestral regions P1 and P2, and the variable loops L1-L4 (Athappilly et al., 1994). The L1 loop 
contain the highest variability among FAdV serotypes and antigenic determinants, and other loop 
regions, except L3, other loop regions are located on the surface of the hexon protein and interact 
with host immune responses (Raue and Hess, 1998). 
The fiber of FAdV is divided into three sections: the N-terminus which binds to the 
immunoglobulin (Ig) domain similar to D1 of Coxsackie and adenovirus receptor (CAR) of 
HAdV (Tamanini et al., 2006); the middle region; and the C-terminus which makes up the knob 
(Figure 1.1. B). Although two fiber molecules are encoded by CELO, the long fiber is 
responsible for a CAR-dependant infection pathway (Tan et al., 2001).  
The FAdVs are estimated to compose 80.7% protein, mostly derived from hexons and 
pentons of the capsid (Laver et al., 1971). The genome of FAdV is composed of 41-45 kbp 
linear, double-stranded DNA (dsDNA) condensed within the virion by virus-encoded core 
proteins (Laver et al., 1971). It replicates unidirectionally by viral DNA polymerase that copies a 
single strand at a time (Laver et al., 1971). Viral transcription utilizes host cellular RNA 
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polymerase II or III with DNA replication and virus assembly in the nucleus, and the virus is 
released upon cell rupture (Wold and Horwitz, 2007). During productive infection most AdV 
induce the synthesis of soluble, complement-fixing Ag of the hexon protein (Sambrook et al., 
1980), and it may be associated with cross-reactivity with other members in the same group or 
other groups (Norrby and Wadell, 1969). Targeting the liver leading to infection of hepatocytes 
occurs with HAdV-5 by attachment of hexon to coagulation factor X (Waddington et al., 2008). 
 
1.4. Adenovirus infections in poultry 
Aviadenovirus consists of the largest number of viruses isolated from a variety of birds 
including turkeys, pigeons, budgerigars and ducks (Cho, 1976; McFerran et al., 1976a; Bouquet 
et al., 1982), guinea fowl (McFerran et al., 1972), ostriches (Gough et al., 1997) and several 
raptor species (Forbes and Simpson, 1997) while domestic chickens (Gallus domesticus) act as 
the primary host (Monreal, 1992). The natural host range of AdV in poultry is confined mostly to 
one species or a few closely related species (Adair and Fitzgerald, 2008). The extreme resistance 
of FAdV to heat, physical and chemical disinfectants, and a wide range of pH is of great 
importance to their distribution and epidemiology (Monreal, 1992). 
Many FAdV infections are often subclinical due to the presence of maternal antibodies 
(Ab) and low virulence of some strains (Adair and Fitzgerald, 2008). Further, multiple and 
complex associations attributed to most FAdV, and their pathogenesis are unclear (McCracken 
and Adair, 1993; Adair and Fitzgerald, 2008). Some serotypes/strains of FAdV belonging to 
Aviadenovirus, Siadenovirus and Atadenovirus correlate directly with specific diseases such as 
QB (Reed and Jack, 2008), hydropericardium syndrome (Mazaheri et al., 1998; Nakamura et al., 
1999); turkey HE (Pierson and Fitzgerald, 2008)  and EDS (Adair and Symth, 2008) 
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respectively. The different tissue tropism and production of diverse disease manifestations by 
different serotypes of FAdV have not been elucidated (Fitzgerald, 2008). Further investigation of 
the differences and factors associated in pathogenicity among field isolates may elucidate the 
pathogenic potential of FAdV infections (Ojkic et al., 2008b).  
 
1.4.1. Pathogenesis of fowl adenovirus infections in chickens 
The alimentary tract and upper respiratory system are considered as primary sites of 
replication for most FAdV (Cook, 1974; Saifuddin and Wilks, 1991a; McCracken and Adair, 
1993; Adair and McFerran, 2008), which are commonly isolated from feces and gastrointestinal 
tract of poultry (Guy, 1998) or the respiratory tract (Adair and McFerran, 2008). Fecal shedding 
has been established as the most consistent and concentrated source of the virus from the 
infected bird (Howell et al., 1970; Cook, 1974). An age-associated virus excretion in feces in 
chicks inoculated with CELO virus has been observed (Clemmer, 1972).  
Under normal conditions, the FAdVs are not highly contagious within a chicken flock, 
and a slow spread over several weeks has been observed in naturally infected flocks (McFerran 
and Adair, 1977). The available evidence suggests that most FAdVs follow the same pattern of 
infection, with initial multiplication of FAdV probably contributes to a cell-free viremia, 
resulting in virus spread to virtually all organs (McFerran and Adair, 1977; Saifuddin and Wilks, 
1991a). During periodic viremic phases, virus is widely distributed to almost all tissues except 
the central nervous system and testis (may be present in semen) (Fadly and Winterfield, 1973; 
Cook, 1974; Adair and Fitzgerald, 2008). The presence of INIB in the intestinal epithelium or 
liver was a constant observation, and indicates those tissues as FAdV replication sites. Highest 
virus replication has been observed in the liver, cecal tonsil and bursa of Fabricius following 
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intramuscular inoculation of FAdV (Romanova et al., 2009). Persistence of FAdV-associated 
with hydropericardium in broiler breeders has been demonstrated (Ashraf et al., 2000). 
Pathogenicity studies have been done by oral or parenteral inoculation of FAdV to day-old SPF 
chickens (Sharples and Jungherr, 1961; Cook, 1974; McCracken et al., 1976; Cook, 1983). 
Results of most natural and experimental studies to investigate the role of most FAdV often were 
inconclusive and varied widely due to different and variable clinical manifestations, serotypes 
(Erny et al., 1991), strains within a serotype (Erny et al., 1991; Pallister et al., 1996), immune 
status of the chickens (Monreal, 1992), different experimental models, geographical distribution 
and variation of minimum lethal dose of inoculation from 4 to >300,000 tissue culture infective 
dose50 (TCID50) per chicken (Barr and Scott, 1988; Erny et al., 1991; Fitzgerald, 2008). 
Pathogenicity studies in commercial chickens with FAdV have used high median TCID50/ml 
dose (1x106 TCID50/0.05 ml)  in primary cell cultures (Okuda et al., 2001). Variable mortality 
rates and lesions observed in these studies indicate that the pathogenesis of FAdV is not 
necessarily serotype dependent (Saifuddin and Wilks, 1990b).  
Infection of chickens with group I avian adenoviruses usually require the presence of 
other co-pathogens such as birnavirus, circovirus or mycoplasma; or exposure to mycotoxin for 
the development of clinical disease (Hess, 2000; Adair and Fitzgerald, 2008). Experimental 
studies done in 1960s and 1970s have supported the hypothesis that FAdV have a role in 
respiratory disease, most probably as a secondary pathogen, intensifying the effects of other 
organisms (McFerran and Adair, 1977). However, a clear relationship between maternally 
derived Ab titer and disease severity has been observed (Saifuddin and Wilks, 1990b). Increased 
pathogenicity of FAdV in chicken has also been observed with co-infections with IBDV and 
Escherichia coli, (Dhillon and Winterfield, 1984).   
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Avian adenoviruses belonging to the genera Aviadenovirus, Atadenovirus and 
Siadnovirus are reported to establish latent infections, which may later result in reactivation and 
vertical transmission (Wigley et al., 2008). The FAdVs are reported to remain latent in SPF 
flocks for at least one generation while the chickens were positive for neutralizing Ab (Fadly et 
al., 1980). Although transient transmission of virus through the embryonating eggs may occur 
during viral replication, mechanisms controlling virus replication and vertical transmission or 
location of latency have not been elucidated (Wigley et al., 2008). However, reactivation of 
FAdV appears to be under the control of steroid hormones, egg production, and possibly with 
stress-induced immunosuppression (McFerran, 1981b; Wigley et al., 2008). Although latency is 
a feature of FAdV (McCracken and Adair, 1993); the location, state of latency and factors 
associate with reactivation are unclear.  
 
1.4.2. Transmission of fowl adenovirus infections in chickens 
The FAdV are known to be commonly transmitted both vertically and horizontally from 
viremic parent flocks to the progeny (McFerran and Adair, 1977). Vertical transmission is 
probably the main method of spread of FAdVs among chicken flocks, but  horizontal 
transmission within a flock occurs readily as the virus  is present in all excretions and in high 
numbers in feces (Adair and Fitzgerald, 2008). With vertical and horizontal transmission,  and  
the ability to persist in the environment, FAdV have evolved as successful pathogens worldwide 
(Adair and Fitzgerald, 2008).  
Vertical transmission of FAdV was first observed in chicken embryos (Yates and Fry, 
1957). FAdV have also been detected in eggs as a contaminant (Du Bose and Grumbles, 1959; 
Cook, 1968).  The FAdV have been isolated from embyronating eggs of SPF chickens inoculated 
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with the virus (Mazaheri et al., 2003), or occasionally in eggs laid within one week post 
inoculation (Yates and Fry, 1968). Vertical transmission has also been demonstrated by detection 
of FAdV DNA in day-old chicks (Grgic et al., 2006). There is no histological evidence of FAdV 
(CELO virus) replication in the oviduct or uterus of infected hens at 3 - 4 days post inoculation 
(Dawson et al., 1981). No virus was detected in oviduct or trachea of SPF chickens at 4 weeks 
following inoculation of  FAdV-8 , but virus was readily detected from the cecal tonsil (Reece et 
al., 1985a). Further, most studies have failed to induce clinical disease in progeny by  inoculation 
of FAdV (Mazaheri et al., 2003). 
Vertical transmission of FAdV appears to correlate with the neutralizing Ab in the blood 
(Cowen et al., 1978a; Dawson et al., 1981). Similarly, development of neutralizing Ab appears 
to coincide with virus excretion (Adair and Fitzgerald, 2008). However, some studies have 
observed vertical transmission of FAdV in the presence of virus neutralizing (VN) Ab (Cowen et 
al., 1978b; Saifuddin and Wilks, 1991b; Mazaheri et al., 2003). Others have observed that 
vertical transmission is prevented in the presence of VN Ab or strong immune response to FAdV 
(Philippe et al., 2007). Strain or serotype specific variations in vertical transmission of FAdV has 
also been reported (Dawson et al., 1981; Mazaheri et al., 2003). As the level of maternal Ab in 
broiler chickens wane at around 3 weeks of age there would be opportunity for suitable strains to 
spread from the intestine and cause disease (Adair and Fitzgerald, 2008). Vertical transmission 
of FAdV associated with IBH has been found in the egg, embryonating egg or newly hatched 
chicks (Reece et al., 1985a; Saifuddin and Wilks, 1991b). Fomites, people and vehicles also can 
be important modes of spread of FAdV (Adair and Fitzgerald, 2008). However, very little is 
known about the behavior of the FAdV in large commercial flocks (Grimes, 2007). 
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1.4.3. Virulence of fowl adenovirus infections in chickens 
A wide range of virulence has been reported within the FAdV (McFerran and Smyth, 
2000). Determinants of virulence of FAdV are poorly characterized (Pallister et al., 1996; Adair 
and Fitzgerald, 2008) and often no correlation is observed between FAdV serotype and virulence 
(Cook, 1983). However, some serotypes, strains or variants of FAdVs have been associated with 
great virulence, as observed in disease outbreaks with very high mortality such as IBH (Kefford 
and Borland, 1979; Reece et al., 1986a; Ojkic et al., 2008a) and HPS/IBH (Ganesh and 
Raghavan, 2000). These FAdV isolates associated with IBH (Erny et al., 1991; Pallister and 
Sheppard, 1996) or HPS/IBH (Ganesh, 1998; Ganesh et al., 2001b) have been analyzed by REA. 
Analysis observed marked genomic differences that helped to classify them as highly virulent, 
mildly virulent or non-pathogenic strains. Studies also support an important role for the fiber in 
infectivity and pathogenicity (Tan et al., 2001). Comparisons of polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP) patterns of intertypic recombinant FAdV 
have shown that differences in the long fiber gene is responsible for virulence of FAdV-1 (CELO 
virus) (Okuda et al., 2006) or FAdV-8 (Pallister et al., 1996) . Although all FAdV are composed 
of two fibers per penton base (Gelderblom and Maichle-Lauppe, 1982), two hypervirulent strains 
of FAdV-8 have been shown to contain only one fiber gene and the length of the whole genome 
is not a determining factor in the virulence of this hypervirulent FAdV-8 strain (Pallister et al., 
1996). Studies indicate that unidentified factors may enhance the pathogenic potential of FAdV 
(Toro et al., 1999). 
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1.4.4. Diagnosis of fowl adenovirus infections  
 Detection of FAdV does not by itself imply clinical disease as they are common in the 
environment, and they have been consistently isolated from healthy chickens (Adair and 
Fitzgerald, 2008). Both conventional and molecular methods are used for the direct detection of 
FAdV, and these have been described and reviewed (McFerran, 1998; Hess, 2000). Diagnosis of 
FAdV infections are routinely carried out by a combination of isolation in cell culture or cell 
lines, histopathology, electron microscopy and genotyping (Hess, 2000).  
Several methods have been described for isolation and identification of FAdV (McFerran, 
1998). Cell cultures and cell lines of chicken liver-origin such as chick embryo liver (CEL) and 
hepatoma cell lines can be used for the recovery of FAdV from specimens (Alexander et al., 
1998; McFerran, 1998; Ojkic et al., 2008b). They produce typical CPE characterized by 
rounding, syncytium formation (which resembles a bunch of grapes), and cell detachment 
(McFerran, 1998) (Figures 1.3. B). Negative stain electron microscopy and thin-section electron 
microscopy have been proved useful for rapid detection of FAdV in suspected material and 
tissues based on their characteristic morphology (Adair and Fitzgerald, 2008) (Figure 1.1). 
Immunohistochemical staining and in-situ hybridization are widely used for direct Ag detection 
from fixed tissues (Saifuddin and Wilks, 1991a; Saifuddin et al., 1991; Goodwin et al., 1996; 
Latimar et al., 1997; Adair and Fitzgerald, 2008). Virus identification with monoclonal Ab 
against FAdV can be used to improve diagnostic assays, study pathogenesis and identify strains 
(Ahmad and Burgess, 2001).  
Several researchers have used PCR alone (Jiang et al., 1999), or in combination with 
RFLP of different regions of the hexon gene as a very sensitive and specific method for 
detection, differentiation and phylogenetic analysis of FAdV (Meulemans et al., 2001; 
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Meulemans et al., 2004; Raue et al., 2005; Ojkic et al., 2008b). Several studies have reported the 
competency of PCR using FAdV-1 hexon, penton and fiber gene for detection of FAdV DNA  
(Hess, 2000; Meulemans et al., 2001); and in combination with REA for differentiation and 
typing of FAdV (Raue and Hess, 1998; Hess et al., 1999; Jiang et al., 1999; Meulemans et al., 
2001). Hence, the application of molecular methods in clinical settings has increased, and PCR 
primers for the hexon gene or fiber gene are frequently chosen because they have hypervariable 
regions among serotypes (Ojkic et al., 2008a; Ojkic et al., 2008b).  
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Figure 1.3. Cytopathic effects of FAdV in cell line. A) Eighty percent confluent Leghorn male 
hepatoma cell line. B) Typical cytopathic effects of cell rounding, refractility and syncitium 
formation at 48 h post-inoculation of FAdV at 1 multiplicity of infection (m.o.i.). 
A B 
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A variety of serological tests have been used to detect Ab against FAdV. Agar gel 
immunodiffusion (AGID) is a simple, inexpensive, and the most commonly used test to detect 
group-specific Ag (Adair and Fitzgerald, 2008). The sensitivity of AGID is increased by the 
incorporation of trivalent Ag (Cowen, 1986). Indirect enzyme-linked immunosorbant assay 
(ELISA) have been developed to detect group and type-specific Ab (Mockett and Cook, 1983; 
Saifuddin and Wilks, 1990a; Maiti and Sarkar, 1997) or antiviral Ab (Ojkic and Nagy, 2003). As 
commercial chicken flocks are often infected with more than one serotype of FAdV, the resulting 
group-specific Ab would mask the detection of type-specific Ab (Mockett and Cook, 1983). 
Designation of a serotype is done by the serum neutralization test, the most sensitive serological 
method available for detecting infection (Grimes and King, 1977b), or by the cross-neutralization 
test (Benko et al., 2005). The fluorescent antibody test has also been used to detect serum Ab 
against FAdV (Adair et al., 1980).  
 
1.5. Immunity against viral infections in chickens 
This innate recognition of viruses involves the interaction of highly conserved, widely 
distributed, and constitutively expressed structures of the pathogens known as pathogen-
associated molecular patterns (PAMPs) with host receptors (Iwasaki and Medzhitov, 2004). 
These innate defense mechanisms operate immediately following a viral infection in poultry, and 
are mainly performed by natural killer (NK) cells, granulocytes, and macrophages. These cells 
identify molecular structures of the invading pathogen; by secretion of antimicrobials and 
cytokines as well as by activation of the adaptive immune response (Jeurissen et al., 2000). 
However, in mammals, PAMPs are detected by a limited number of cellular sensors (Russell, 
2009) mainly, dendritic cells (DC) and Toll-like receptor-9 (TLR9) (Yamaguchi et al., 2007). 
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The TLR family is a highly conserved group of molecules that play a major role in the 
detection of PAMPs and the initiation/regulation of immune responses (Philbin et al., 2005). In 
mammals, the viral DNA sensing TLR namely TLR9, recognizes genomic DNA, TLR7 and 
TLR8 recognize single strand RNA, and TLR3 recognizes double strand RNA (Alexopoulou et 
al., 2001; Heil et al., 2004) upon degradation in the endosome (Takeda and Akisho, 2005). 
The chicken genome consists of many immune related-genes, including those coding for 
cytokines, chemokines, Ag, cell surface protein receptors and MHC-associated genes (Moore et 
al., 2005). The FAdV genome also contains significant numbers of genes to modulate the host 
immune response such as inhibition of interferon functions by virally associated RNA and the 
E1A gene, inhibition of intrinsic cellular apoptosis in infected cells, and the prevention of MHC1 
expression on the cell surface are available (Mahr and Gooding, 1999). However, the divergence 
between mammalian and fowl adenoviruses had made it difficult for FAdV to produce candidate 
immunomodulators (Schat and Skinner, 2008). Innate and humoral immune systems of the host 
are involved in the immune response to AdV. Major structural components of capsid of the virus 
(Burgert et al., 2002) mainly hexon, penton and fiber are key integrators in these responses. 
 
1.6. Immunity against fowl adenovirus infections in chickens 
The innate and humoral immune systems of chickens are essentially similar to those of 
mammalian counterparts (Schijns et al., 2008). The innate immune system of chickens is an 
early responding system with a cellular response mediated by DC, macrophages, epithelial cells, 
NK cells and various granulocytes with no clonal expansion (Schijns et al., 2008). Activation of 
antigen presenting cells (APCs) such as DC and macrophages occurs through receptors 
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recognizing non-self, microbial “stranger” signals or endogenous “danger” molecules from 
damaged tissues (Janeway, 1992). 
Antigens can be sampled from the environment upon recognition of conserved structures 
of microbes by APC such as DC, macrophages and B lymphocytes by micropinocytosis, 
phagocytosis and receptor-mediated absorption endocytosis, respectively before processing and 
presenting Ag fragments to adaptive T lymphocytes. The adaptive immune system of chickens 
could be subdivided into two major areas: humoral (Ab based) and cell-mediated immunity 
(CMI) (Schijns et al., 2008). 
Chicken T lymphocytes are the most important cell type of CMI which are functionally 
differentiated by the presence of surface molecules on the surface of CD4+ and CD8+ T  (cluster 
of differentiation) helper T (Th) lymphocytes and cytotoxic T lymphocytes (CTL), respectively 
(Sharma, 2008). Upon presentation of Ag by APCs, the T lymphocytes become activated, which 
leads to proliferation and initiation of an immune response against the Ag (Maccubin and 
Schierman, 1986). The CMI mediated through Ag-specific CD8+ CTL is the most important host 
defense against many viruses, including AdV as they eliminate virus-infected cells, and result in 
an Ag-specific clonal expansion, and augmentation of the immune response (Kojaoghlanian et 
al., 2003).  
The B and T lymphocytes of the humoral system carry single receptors specific for their 
cognate Ag, which results in clonal expansion and generation of Ag-specific, memory B and T 
lymphocytes (Ratcliffe, 2008; Viertlboeck and Gobel, 2008). Chickens infected with FAdV 
produce group-, type- and subtype-specific Ab (Adair and Fitzgerald, 2008). Adaptive immune 
response involves activation of Ag-specific Th cells in lymphoid organs by APC amplification 
regulated by cytokines, co-stimulatory molecules, macrophages, CTLs and B cells. During 
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virulent infection, DC cells receive stimulus from the pathogen leading to maturation and 
activation, and when the stimulus is absent tolerance or insufficient priming for an effector Th 
cell-dependant immune response occurs (Schijns, 2006). Hence, priming and clonal expansion of 
Ag-specific Th lymphocytes occurs through a two-signal model, and absence of the second 
signal can lead to clonal anergy, tolerance and deletion of antigenic stimulation (Jull-Madsen et 
al., 2008). Bridging between the innate and the adaptive immune systems by APCs is essential 
for effective downstream priming and regulation of antimicrobial and vaccine-induced immunity 
(Kaspers et al., 2008; Schijns et al., 2008).  
Apart from cell-to-cell interaction, there are several locally active cytokines that act as 
the master regulators of the immune system (Kaiser and Staheli, 2008). In chickens, induction of 
an adaptive immune response is controlled by help from Ag specific CD4+ Th cells (Arstila et 
al., 1994). The selection of the immune response is controlled by Ag-specific, Th1 phenotype-
skewed polarization as evidenced by the identification of orthologous Th1 cyokines including  
chicken interferon (chIFN-γ), chicken interleukin-12  (chIL-12), chIL-18 (Staeheli et al., 2001; 
Degen et al., 2004) and chIL-5 (a non-functional, apparent pseudogene) (Kaiser and Staheli, 
2008).   
In chicken, immunoglobins (Ig) are very effective in preventing infection with many 
viruses, when the virus passes through blood before reaching its target tissue (Powell, 1987). 
They can protect against viral infections by neutralization, blocking the attachment to target site 
and antibody-dependant cytotoxicity (Powell, 1987). The homologues of IgG (named IgY), IgM 
and IgE are assumed to contribute to neutralization of microbes by complement activation and/or 
opsonozation by NK cells, macrophages and monocytes (Jull-Madsen et al., 2008; Schijns et al., 
2008). The AdV hexon, fiber, and to a lesser extent, the penton have been shown to be the major 
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targets for neutralizing Ab (Toogood et al., 1992). IgY, the major isotype in chicken sera, is 
produced after IgM in the primary Ab response, and it is the main isotype produced in the 
secondary response (Davison et al., 2008). Maternally derived Ab (MDA) from infected or 
vaccinated hens have been shown to protect the progeny against a virulent challenge with viruses 
such as MDV, NDV, IBDV, IBV and reovirus (Calnek and Smith, 1972; van der Heide et al., 
1976; Darbyshire and Peters, 1985; Schijns et al., 2008).  
Different pathogens induce distinct types of host immune reactions and pathogens are 
opposed by the host adaptive immune responses, i.e. the immunological correlate of protection 
(IMCOP) (Schijns et al., 2008). The most important host defense against many viruses including 
AdV is cell-mediated immunity (CMI) (Kojaoghlanian et al., 2003). AdV contains at least 14 
structural proteins (Li et al., 1984), and the functional properties of these proteins may play a 
crucial role in the outcome of infection, as shown with HAdV (Russell, 2009). Overall, the 
findings support the contention that the immune response to virus occurs through Ag-specific 
Th-1 driven cytokines, promoting CMI directed CTL to destroy virus-infected cells, and by NK 
and macrophage activation for cytolysis and phagocytosis. The ubiquitous nature of FAdVs and 
their inherent stability, together with modern high-density confinement rearing practices makes 
elimination of these viruses from poultry flocks impossible.  
FAdV-specific Ab are commonly found in breeder and layer chickens, and exposure to 
multiple serotypes is well established (Cowen et al., 1977; Grimes et al., 1977a; Adair et al., 
1980; Adair and Fitzgerald, 2008). Chicks with maternally-derived Ab (MDA) against FAdV are 
still susceptible to infection and may excrete virus, however, dissemination from the primary site 
of multiplication to the secondary site may be prevented (McFerran, 1981b). Experimental work 
has shown that maternal Ab wanes within 4 weeks of life and its presence does not prevent 
  34 
infection with some serotypes but it presumably prevents latent virus activation (Kohn, 1962). 
Maternal Ab prevents disease following intra-abdominal infection of FAdV (Fadly and 
Winterfield, 1973; Grimes and King, 1977). Following infection, development of neutralizing 
Ab coincides with decline of virus replication and excretion (Cook, 1974).  
Antibodies transmitted from the hen via the yolk can protect the chicken against early 
infection with FAdV (Saifuddin and Wilks, 1991b). Immunization of 3 - 4 week old broiler 
chickens with live, attenuated FAdV by the eye drop method followed by heterologous challenge 
elicited no cross-protection, but satisfactory protection lasting 4 weeks was induced by 
monovalent homologous immunization (McFerran and Adair, 1977; Winterfield et al., 1977). 
Many studies have shown that antiviral Ab against FAdV have been detected in layer and broiler 
chickens by ELISA one week following intramuscular inoculation, and peak titers were seen in 3 
weeks (McFerran, 1981a; Mockett and Cook, 1983; Saifuddin and Wilks, 1991a; Maiti and 
Sarkar, 1997; Ojkic and Nagy, 2003). Secondary stimulation with the same FAdV serotype 
boosted the immune response eight fold (McFerran, 1981a) while other studies demonstrated  
only a slight effect 4 weeks following inoculation with a  homologous or heterogenous serotype  
(Mockett and Cook, 1983).  
 
1.7. Fowl adenoviruses as models of gene delivery vectors 
The vast majority of knowledge on AdV virion properties, genomic organization and 
replication comes from studies done on HAdV, most frequently HAdV-2 and HADV-5 (Benko 
et al., 2005). The FAdVs are of emerging interest as gene delivery vectors for production of 
recombinant vaccines for humans and animals due to greater understanding of their biology, lack 
of serological similarity to Mastadenoviridae, sequence homology to HAdV, larger genomic 
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capacity to accommodate foreign gene inserts, defective replication in human cells (Russell, 
2000; Nagy, 2001) and the non-infectious nature of FAdV, as shown in a variety of human and 
non-human cell lines (Francois et al., 2001; Cherenova et al., 2004).  
Biological and genomic characterization of most FAdV have been established: FAdV 1 
(CELO virus) (Chiocca et al., 1996), FAdV-4, FAdV-8 (Ojkic and Nagy, 2000) FAdV-9; FAdV-
10 (Sheppard et al., 1995; McCoy and Sheppard, 1997) or regions of FAdV genome: FAdV-2, 
FAdV-4 , and FAdV-10 (Erny et al., 1995; McCoy and Sheppard, 1997; Corredor et al., 2008). 
FAdV-10 (Sheppard et al., 1998a) have the largest genome among members of family 
Adenoviridae (Chiocca et al., 1996; Ojkic and Nagy, 2000). The FAdV-1 (CELO), FAdV-8, 
FAdV-9 and FAdV-10 are extensively studied as potential gene expression vectors (Michou et 
al., 1999). The FAdV are also currently under investigation as gene expression vectors in human 
cancer and gene therapy due to their no or low pathogenicity for their natural host, and genomic 
and structural similarity to HAdV (Bangari and Mittal, 2006).   
The FAdV genome has been shown to contain multiple sites for insertion of foreign 
genes with no influence on virus replication, tissue distribution or immune response (Michou et 
al., 1999; Ojkic and Nagy, 2001; 2003). The FAdV-1 genome contains approximately 5 kbp 
sequence at the left end and a 12 kbp sequence at the right end which are rich in open reading 
frames (Michou et al., 1999). CELO virus has been developed as a FAdV-based vector for 
cancer gene therapy (Shashkova et al., 2005). The CELO vector is exceptionally stable, 
inexpensively grown in chicken embryos, and can be used as a useful alternative to HAdV based 
vectors (Michou et al., 1999). 
Recombinant vectors based on FAdV-1 (CELO virus), FAdV-8, FAdV-9 and FAdV-10 
have been reported for immunomodulatory gene expression of ChIL-2 and chicken 
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myelomonocyte growth factor (Sheppard et al., 1998b; Michou et al., 1999; Johnson et al., 2000; 
Ojkic and Nagy, 2001; Lowenthal et al., 2005). FAdV-1 (Sheppard et al., 1998b). FAdV-10 
(Johnson et al., 2003) vectors  expressing IBDV VP2 protein are used as a vaccines to immunize 
chickens against IBD. Vaccinating chickens with recombinant FAdV-8  S1 gene of IBV 
(Johnson et al., 2003) or chicken gamma interferon gene  inserted in the vector have been shown 
to provide protective immunity against infectious bronchitis and IBH, respectively.  
The viral genomes of FAdV-1 and FAdV-9 have been screened for regions that could be 
deleted and would tolerate insertion of marker genes followed by production of viable virus 
(Michou et al., 1999; Ojkic and Nagy, 2001). Deletion of the long tandem repeat region 2 of the 
right end of the FAdV-9 genome (Ojkic and Nagy, 2003) or deletion of open reading frames in 
the right end of CELO (Le Goff et al., 2005) and insertion of a foreign reporter gene is well 
tolerated, and these manipulations did not significantly alter the distribution, replication, and 
immune response compared to the wild type virus. The FAdVs have also been studied 
extensively as potential candidates of vaccine delivery vehicles or a vector for recombinant 
protein production in both humans and chickens (Francois et al., 2001).  FAdV-1 containing a 
human IL-2 gene has been examined for cancer therapy in a mouse model of subcutaneous 
melanoma (Francois et al., 2001; Shashkova et al., 2005).  
 
1.8. Inclusion body hepatitis  
 1.8.1. Inclusion body hepatitis in broiler chickens  
Inclusion body hepatitis (IBH) is an important, acute, viral disease of broiler chickens  
between 2-7 weeks of age (Adair and Fitzgerald, 2008). Outbreaks of IBH have also been 
reported in two-week old broiler breeders (El-Attrache and Villegas, 2001; Philippe et al., 2007); 
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and layer chickens (Hoffmann and Dorn, 1977; Reece et al., 1986a). IBH is characterized by a 
sudden onset of mortality of 1 - 10%, and occasionally exceeding 30% (Barr and Scott, 1988). 
The disease has a short clinical course of 4-5 days (Adair and Fitzgerald, 2008). IBH is a classic 
example of a viral-induced hepatic injury (Abdul-Aziz et al., 2008) and the affected chickens 
typically have pale, friable and swollen livers, with focal to extensive necrosis with large, 
basophilic, INIB in degenerating and necrotic hepatocytes (Reece et al., 1986a; Abdul-Aziz et 
al., 2008). All serotypes have been associated with outbreaks of IBH in chickens: FAdV-1 
(Singh et al., 1996), FAdV-2, FAdV-3 and FAdV-4 (McFerran et al., 1976b; Grimes and King, 
1977b); FAdV-4 (Mazaheri et al., 1998); FAdV-5 (Fadly and Winterfield, 1973; McFerran et al., 
1976b); FAdV- 6 , FAdV-7, FAdV-8, FAdV-8a, FAdV-8b and FAdV-11 (Grimes et al., 1977b; 
Kefford and Borland, 1979; Ojkic et al., 2005; Ojkic et al., 2008a); FAdV-9 (Grimes et al., 
1978a); FAdV-7 and FAdV-10 (Barr and Scott, 1988); FAdV-11 (Mendelson et al., 1995); 
FAdV-12 (Saifuddin et al., 1992). 
IBH was first described in broiler chickens as a disease of “unknown significance” with 
necrotizing hepatitis and INIB in hepatocytes (Helmboltd and Fraizer, 1963). A similar disease 
identified as ‘inclusion body hepatitis’ was first reported in 1970 in Canada (Howell et al., 
1970). Although presence of INIB were highly suggestive of viral involvement, the initial reports 
were unable to elucidate an etiology (Helmboltd and Fraizer, 1963; Howell et al., 1970). Later, 
the cause of this disease was demonstrated as a viral agent (Fadly and Winterfield, 1973); and 
suspected to be an AdV (Bickford et al., 1973; Antillon and Lucio, 1974). Later, the disease was 
experimentally reproduced in broiler chickens with isolates from field outbreaks (Fadly and 
Winterfield, 1973; Wells and Harrigan, 1974). Since then, IBH has been reported in North 
America (Gomis et al., 2006), Europe (Young et al., 1972; Hoffman et al., 1975; McFerran et 
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al., 1976b), New Zealand (Green and Clarke, 1976; Christensen and Saifuddin, 1989) ; Australia 
(Wells et al., 1977; Reece et al., 1986a; Grimes, 1992), Japan (Itakura et al., 1974b; Otsuki et 
al., 1976)  Mexico (Antillon and Lucio, 1974; Sarfati, 1991) and several Central and South 
American countries (Toro et al., 1999; Toro et al., 2000).  
 
1.8.2. Inclusion body hepatitis in other birds 
Outbreaks of IBH has also been reported in other avian species, including turkeys (Guy et 
al., 1988; Takase et al., 1990; Shivaprasad et al., 2001), pigeons (McFerran et al., 1976a; 
Goodwin and Davis, 1992; Ketterer et al., 1992), geese (Goodwin and Davis, 1992; Ketterer et 
al., 1992), quail (Riddell, 1984); psittacine birds (Jack et al., 1987; Bradley et al., 1994; Grewal 
et al., 1994), raptors (Ramis et al., 1992; Capua et al., 1995), kestrels (Schelling et al., 1989; 
Oaks et al., 2005), pheasants (Tomaszewski and Phalen, 2007); and a tawny frogmouth (Rosen et 
al., 1965). A group I AdV characterized as turkey AdV-2 has been responsible for IBH in day 
old turkeys (Reece et al., 1985b). Adeno virus-like particles also have been detected in wild 
psittacine birds (Guy and Barns, 1997) and Japanese quail (Scott et al., 1986; Gomez-
Villamandos et al., 1992) affected with IBH. In these outbreaks, in addition to liver, INIB have 
been observed in pancreas of several species: pigeon (Seok et al., 2005), guinea fowl (Ketterer et 
al., 1992), parrot (Ramis et al., 1992), merlin (Reece and Pass, 1986) and kestrel (Schelling et 
al., 1989).  
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1.8.3. Inclusion body hepatitis as a secondary disease in chickens 
Historically, IBH has been considered as a secondary disease as most outbreaks have 
occurred with prior or concurrent association with common immunosuppressive disease agents 
such as IBDV (Sileo et al., 1983), CIAV (Rosenberger et al., 1975; Fadly et al., 1976; Fadly and 
Winterfield, 1977; Grimes and King, 1977b), IBDV and CIAV (Rosenberger et al., 1974; 
Rosenberger et al., 1975; Toro et al., 2000; Toro et al., 2001b), or reovirus (Davis et al., 1991; 
Adair and Fitzgerald, 2008). Inclusion bodies from natural cases of IBH have been shown to 
contain FAdV and parvovirus (McFerran et al., 1976a; Hussain et al., 1981). These 
immunosuppressive diseases (IBD, CIAV and reo viral infections) also have been shown to 
enhance the pathogenicity of IBH (Bergmann, 1978), and in many instances, bacterial infections 
are believed to have occurred as a sequela (Fadly et al., 1976). Immunosuppressive agents such 
as cyclophosphamide (Rosenberger et al., 1975; Fadly et al., 1976) or mycotoxins (Sandhu et al., 
1995) also have been shown to enhances the pathogenicity of FAdV causing IBH. Damage to the 
bursa of Fabricius of broiler chickens seen in field cases of IBH in Saskatchewan, Canada is 
thought, but not proven to be caused by IBDV (Little et al., 1988).  
Most pathogenicity studies have been done in SPF chickens by inoculation of FAdV 
through natural routes with isolates obtained from outbreaks of IBH (Nakamura et al., 2003a). 
Experimental studies with virulent strains of FAdV have been shown to reduce humoral and 
cellular immune responses in broiler chickens (McCracken et al., 1976; Erny et al., 1991; 
Saifuddin and Wilks, 1991a) and SPF chickens (Grimes et al., 1977b; Saifuddin and Wilks, 
1992; Singh et al., 2006). However, natural cases (Schonewille et al., 2008) and experimental 
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studies (Macpherson et al., 1974) suggest a co-infection with IBDV is not necessary to produce 
IBH.  
Variability and discrepancies in these studies have been attributed to different serotypes 
and strains of FAdV, age, immune status, infective titer (Toro et al., 2000), virulence of strains 
(Barr and Scott, 1988; Saifuddin and Wilks, 1990b; Monreal, 1992) and susceptibility 
differences among  chicken lines (Erny et al., 1991). An extensive review on FAdV and avian 
adeno-associated virus (AAV) summarizes that group I Aviadenovirus require an impairment of 
the immune response to express their pathogenic potential in domestic fowl (Cowen et al., 1996). 
Overall, strain specific variations may be the reason for the underlying heterogeneity of the 
FAdV serotypes (Monreal, 1992).  
 
1.8.4. Inclusion body hepatitis as a primary disease in broiler chickens 
Inclusion body hepatitis is the most economically important disease caused by FAdV 
(Grimes, 2007). IBH was postulated as a primary disease when it was diagnosed in a SPF 
cockerel (Grimes, 2007). Later, outbreaks of IBH and experimental studies with FAdV isolated 
from IBH outbreaks in Australia, New Zealand, Canada, and USA underlines their role as a 
primary pathogen with no association or correlation with infections due to IBDV, CIAV, 
reticuloendotheliosis virus or avian leukosis virus J subtype (Macpherson et al., 1974; Grimes 
and King, 1977a; Reece et al., 1986b; Barr and Scott, 1988; Christensen and Saifuddin, 1989; 
Erny et al., 1991; Pallister et al., 1996; Zavala et al., 2002; Gomis et al., 2006). 
Multiple serotypes (FAdV-1 to FAdV-8) and unclassified isolates have been isolated 
from outbreaks of IBH (Macpherson et al., 1974; Grimes et al., 1977b; Reece et al., 1986a; Barr 
and Scott, 1988; Christensen and Saifuddin, 1989; Erny et al., 1991; Pallister et al., 1996; Zavala 
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et al., 2002; Gomis et al., 2006). Epidemiological observations of Australian outbreaks of IBH 
suggests FAdV-8 as the most virulent and most commonly isolated serotype (Grimes, 2007). 
Clinical signs of anemia, necropsy lesions of pale bone marrow and thymic atrophy, and 
secondary infections, which are commonly seen with infections due to CIAV, were not common 
features of Australian outbreaks of IBH (Grimes, 2007). However, diminution and depletion of 
lymphoid follicles in the bursa of Fabricius, thymus and spleen with the absence of 
immunosuppressive agents have been observed in natural cases of IBH in New Zealand (Grimes, 
2007). Some studies indicate that IBH could be reproduced in SPF chicks by intramuscular 
inoculation of FAdV (Grimes et al., 1977b; Grimes et al., 1978a). Progeny of a majority of 
broiler breeder flocks in Saskatchewan, Canada which suffered outbreaks of IBH had 
satisfactory levels of maternal Ab against IBDV (Little et al., 1988). 
 
1.8.5. Pathology of inclusion body hepatitis  
Viral infections in which the liver is the primary target site of involvement is well 
established in humans, laboratory animals and several domestic animals (Little et al., 1988). In 
most studies with IBH in the 1960s and 1970s, the observed INIB in hepatocytes were 
eosinophilic on hematoxylin and eosin (H&E) staining (Bickford, 1972). However, the inclusion 
bodies of natural cases of IBH reported in the 1990s and 2000s were basophilic on H&E staining 
(Helmboltd and Fraizer, 1963; Howell et al., 1970; Pettit and Carlson, 1972; Young et al., 1972). 
Ultrastructural studies of natural outbreaks revealed that virus particles were present in 
basophilic inclusions, and often form crystalline arrays (Adair and Fitzgerald, 2008) while  
eosinophilc inclusions contained few or no virus particles and corresponded to fibrilar, granular 
material (Itakura et al., 1974b). Necrotizing pancreatitis with INIB in acinar cells, as an 
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additional lesion has been observed in field cases of IBH in broiler chickens (Pettit and Carlson, 
1972; Bickford et al., 1973; Bergmann, 1978), and in experimental studies with FAdV (Grimes 
et al., 1978a; Reece et al., 1986a; Pilkington et al., 1997).  
 
1.8.6. Natural and experimental studies with inclusion body hepatitis 
Natural cases and experimental studies with IBH in chickens have been associated with a 
wide range of clinical manifestations including hydropericadium and anemia  (Gallina et al., 
1973; Grimes et al., 1977b; Grimes et al., 1978a); gizzard erosions, necrotizing pancreatitis and 
hypoglycemia (Cowen, 1992; Mazaheri et al., 1998), ventriculitis (Grimes et al., 1977b; 
Goodwin, 1993; Tanimura et al., 1993; Nakamura et al., 2003a); tenosynovitis (Goodwin, 1993); 
respiratory disease (Jones and Georgiou, 1984); enteritis, lymphoid depletion and anemia 
(McFerran et al., 1971) and yellow discolouration of subcutaneous and abdominal fat (Grimes et 
al., 1977b; Hoffmann and Dorn, 1977; Cook, 1983; Reece et al., 1986a). Presence of basophilic 
INIB in epithelial cells of affected tissues has been a common, consistent observation in these 
studies. In most instances, experimental reproduction of these diseases or syndromes with several 
isolates of FAdV were not successful when natural routes were used (Yates and Fry, 1957) or 
when systemically inoculated (Kawamura and Horiuchi, 1964; McDougald and Peters, 1974). 
Failure to do so has resulted in speculation that the association of other agents is needed to cause 
disease (Kawamura and Horiuchi, 1964; Barr and Scott, 1988; Christensen and Saifuddin, 1989; 
Monreal, 1992). Different strains of FAdV isolated from cases of IBH resulted in variable 
lesions, and none were identical to those isolated from disease outbreaks (McFerran, 1981a).  
Disease was reproduced in very young chicks by inoculation of FAdV using natural 
(McCracken et al., 1976) or parenteral routes (Erny et al., 1991). Occasionally, disease has also 
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been reproduced in older chickens by natural routes (Fadly and Winterfield, 1973; Grimes et al., 
1977b). In initial outbreaks of IBH, the INIB in hepatocytes were bright eosinophilic and 
surrounded by a halo (Adair and Fitzgerald, 2008). In other studies, the inclusion bodies were 
basophilic (Howell et al., 1970; Macpherson et al., 1974; McFerran et al., 1976a). Some studies 
were able to produce liver lesions with basophilic, INIB (Sharples and Jungherr, 1961; 
McCracken et al., 1976; McFerran et al., 1976b). 
 
1.8.7. Vertical transmission of inclusion body hepatitis in broiler chickens 
Vertical transmission is an important and effective method of spread of FAdV 
(McCracken et al., 1976; Grimes et al., 1977b; Saifuddin et al., 1992). FAdVs are transmitted 
through the embryonated egg; and often are reactivated in cell culture prepared from embryos 
and young chicks derived from infected breeder flocks (Fitzgerald, 2008). Epidemiological 
evidence from outbreaks of IBH in broiler flocks less than 14 days of age in Australia (McFerran 
and Adair, 1977) and New Zealand (Grimes, 2007) suggest that they were due to vertical 
transmission of FAdV-8. Outbreaks of IBH are thought to be due to vertical transmission of 
FAdV-3 in USA (Pilkington et al., 1997); and FAdV x11a-like virus, FAdV-8 or FAdV-11 in 
Canada (Gomis et al., 2006). Vertical transmission of FAdV associated with IBH have been 
detected in eggs derived from broiler breeder chickens by indirect ELISA (Saifuddin and Wilks, 
1991b). In Canada and Australia, IBH outbreaks have mostly occurred in poultry companies that 
had superior biosecurity and sanitation programs in their breeder operations (Saifuddin and 
Wilks, 1991b). In the early 1980s, peracute outbreaks of IBH occurred in progeny of a single 
broiler breeder flock placed in different states (Pilkington et al., 1997; Grimes, 2007). Vertical 
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transmission of FAdV and CIAV concurrently have been observed following simultaneous 
inoculation of  FAdV associated with IBH, and CIAV in layer breeders (Grimes, 2007).  
 
1.8.8. Inclusion body hepatitis in broiler chickens in Canada 
IBH was initially reported in twelve Canadian broiler flocks as a necrotizing hepatitis 
(Toro et al., 2001b), and subsequently, in eighty six outbreaks with additional lesions such as 
depletion in bursa of Fabricius, and other lymphoid tissues, aplasia of bone marrow, and 
hemorrhagic lesions in fat and muscles (Howell et al., 1970). Later, IBH was observed in 
Western Canadian provinces as an “emerging disease” with no hemorrhagic lesions and anemia 
(Pettit and Carlson, 1972). Since 2001, IBH has been an emerging, economically important 
disease in the broiler industry of western Canadian provinces, Ontario and Quebec (Howell, 
1974). An increase in the number of outbreaks due to several FAdV serotypes has been observed 
in several Canadian provinces (Ojkic et al., 2003; Martin et al., 2005; Gomis et al., 2006; Martin 
et al., 2007; Ojkic et al., 2008a; Ojkic et al., 2008b). Although, there are no comprehensive 
studies conducted in Canada to determine the economic impact of IBH to the broiler industry, 
IBH is estimated to result an  annual loss of $ 300,000  to the Ontario broiler industry (Sanei, 
2009).   
Based on hexon gene loop 1 sequencing analysis, isolates from Canadian outbreaks of 
IBH were genetically related to FAdV-2 strain P7-A, FAdV-x11a, FAdV-8a strain TR-59,  
FAdV-8a/8b strain Ontario (equal percentage identity to FAdV-8a strain T8-A and FAdV-8b 
strain 764), and FAdV-11 strain 1047  (Gomis et al., 2006; Ojkic et al., 2008a).  Lesions such as 
anemia, paleness of bone marrow and lymphoid depletion were neither constantly present nor 
absent in these outbreaks. FAdV x11a-like virus, FAdV-8a strain TR-59, FAdV-8a/8b strain 
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Ontario, and FAdV-11 strain 1047 have been responsible for IBH outbreaks in Saskatchewan 
(Ojkic et al., 2008b). 
 
1.8.9. Prevention of inclusion body hepatitis in broiler chickens 
 1.8.9.1. Control of inclusion body hepatitis through vaccination 
Most cases of acute IBH are the result of vertical transmission of FAdV, and ensuring 
that breeder flocks have seroconverted prior to the onset of lay can prevent the disease (Grimes, 
2007). Maternal Abs have been shown to protect broilers  against an experimental challenge of 
IBH by vaccinating broiler breeders  twice with an autogenous killed vaccine (Alvarado et al., 
2007). Effective protection of progeny by dual vaccination of layer breeders against IBH and 
CIAV has been shown to protect progeny against challenge with FAdV associated with IBH 
(Toro et al., 2001a).  
Immunization of chickens with polyvalent vaccines containing live, attenuated FAdV-1, 
FAdV-2 and FAdV-3 elicited satisfactory protection against the homologous serotype while no 
protection was observed against heterogeous serotypes (Fadly and Winterfield, 1975). In 
Australia, adoption of appropriate vaccination programs against CIAV, MDV and IBDV 
including the use of live, virulent vaccine containing FAdV-8b to vaccinate replacement breeders 
in mid-rearing, has been able to prevent acute IBH outbreaks in the progeny (Grimes, 2007) .  
However, with the evidence of vertical transmission of IBH in chickens, and resistance to early 
infection provided by MDA, immunization of breeder chickens was suggested in the 1970s as 
the best approach to control IBH (Grimes, 2007).  
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 1.8.9.2. Adjuvants as immunoenhancing components in poultry vaccines 
Adjuvants are supplementary, formulated heterogenous compounds or additives that are 
incorporated with Ag to enhance the type, strength and kinetics of the host’s immune system. 
They are broadly classified into two functional groups as signal 1 facilitators and signal 2 
facilitators, however, the exact mechanism remains unidentified (Schijns, 2006). The signal 1 
facilitators influence the delivery of Ag to immunological sites; and the signal 2 facilitators 
directly activate the immune system either as “stranger signals” from pathogens (Janeway, 1992) 
or as inducers of endogenous “danger” molecules (Klinman et al., 2004).  In inactivated 
vaccines, Ag recognized by the adaptive T and/or B cells determines the specificity of the 
immune response and adjuvant determines most other aspects of the immune response. Vaccine 
delivery systems are particulate, and include emulsions, microparticles, immunostimulatory 
complexes (ISCOMs) and liposomes that target associated antigens into APCs such as DCs and 
macrophages (Schijns, 2006).  
Live and whole-inactivated vaccines have been developed and licensed; and vaccination 
of poultry against several viral, bacterial and protozoal pathogens administered as monovalent or 
multivalent vaccines is a common practice worldwide (Schijns et al., 2008). Design of 
vaccination programs is based on factors such as geographical area, contamination levels by 
virulent field strains, serotypes, and regulatory issues (Glisson and Kleven, 1993).   
Most of the commercially available inactivated poultry vaccines are available as water-
in-oil (W/O), oil-in-water (O/W), saponins and alum based formulations The W/O formulations 
are assumed to form an inert depot from which the Ag is release slowly over a prolonged period 
and generates a sufficient Ab response (Hilgers et al., 1998). The O/W emulsions have an oil 
phase of 15 - 25%, and are safe, and quickly release Ag from the water phase, but evoke a 
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strong, short term immune response (Ioannou et al., 2002). The O/W emulsified vaccines contain 
animal, vegetable or synthetic oils that are shown to be suitable for poultry vaccines (Stone, 
1997).   
Conventional inactivated and subunit vaccines are generally formulated with adjuvants 
such as aluminium salts (aluminium hydroxide or alum, and aluminium hydroxyphosphate) 
(HogenEsch, 2002), emulsions or suspensions to enhance the immunostimulatory effects. Alum, 
the most extensively used adjuvant in commercial vaccines, mainly skews the immune response 
towards a T-helper type 2 (Th2) response against protein Ag (Comoy et al., 1997).  
Adjuvants such as Emulsigen® (MVP Laboratories, Inc., Omaha, NE) combined with 
dimethyl dioctadecyl ammonium bromide (DDA) also generate a Th2 type immune response 
accompanied with host inflammation at the site of injection due to the adjuvant (Willson et al., 
1995). This preparation is commercially available as EMULSIGEN®-D, a licensed, mineral, 
stable O/W emulsified adjuvant that is widely used in commercial veterinary vaccines (Mutwiri 
et al., 2004), and is believed to create a depot at the site of injection from which the Ag is slowly 
released for prolonged stimulation of the immune system (Ioannou et al., 2002; Linghua et al., 
2006). DDA, a lipophilic quarternary amine adjuvant (Hilgers and Snippe, 1992) combined with 
other immunoenhancing compounds has been shown to augment humoral and CMI in chickens 
that were given experimental vaccines against IBD (Roh et al., 2006) and ND (Rijke et al., 
1998). 
Immungenicity and protective effects of cytosine-phosphate-guanosine 
oligodeoxynucleotide (CpG-ODN) has been demonstrated in bacterial disease models using 
broiler chickens (Gomis et al., 2003; Gomis et al., 2007). Intramuscular injection of Escherichia 
coli bacterin vaccine formulated at the recommended concentration of EMULSIGEN®-D has 
  48 
been shown not to protect broiler chickens against a lethal challenge, but nevertheless to cause 
damage at the site of injection (Gomis et al., 2007). Minimal immunity is induced at 
concentrations of Emulsigen® lower than recommended levels (Babiuk et al., 2003). 
Live poultry vaccines induce a variety of innate and adaptive immune responses, while 
inactivated vaccines are most commonly used to vaccinate layer and breeder chickens, to boost 
immunity against many diseases following priming with live vaccines, and to confer protection 
in progeny by transfer of maternal Ab (Schijns et al., 2008). Inactivated vaccines contain high 
concentrations of virus, chemically inactivated by formalin or betapropiolactone, are commonly 
formulated with adjuvants, and are administered by subcutaneous or intramuscular injection 
(Glisson and Kleven, 1993). 
 
1.9. Avian adeno-associated virus in chickens 
Adeno-associated viruses are serologically distinct species that are classified together in 
the genus Dependovirus as, mammalian and avian adeno-associated viruses (AAV) (Siegl et al., 
1985; Berns and Parrish, 2007). The AAV found in chickens is a small-sized (18-20 nm), helper-
dependent, defective parvovirus with one known serotype that consistently accompanies most 
FAdV natural cases and laboratory propagation with no relationship to avian disease (Mockett 
and Cook, 1983; Yates and Piela, 1993). They are also present as a contaminant in avian 
adenoviral stock (El Mishad et al., 1975). The virion is composed of viral proteins that 
encapsulate a linear, 4.7-kb single, stranded DNA (Berns and Parrish, 2007). The AAV produce 
infective progeny only in cells co-infected with ‘helper’ AdV, or herpes viruses or in FAdV-1 
DNA transfected chicken cell cultures (Bauer et al., 1986; Bauer and Monreal, 1988; Bauer et 
al., 1990; Tattersall et al., 2005). 
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The first AAV was observed by electron microscopy in  preparations of  tissues affected 
with QB (Dutta and Pomeroy, 1967).  The first AAV was also isolated from the same strain of 
FAdV (Yates et al., 1973).They are widely distributed and highly prevalent in poultry flocks, 
however, they may not present concurrently with every FAdV infection (Yates et al., 1976; 
Saifuddin et al., 1992). They are frequently recovered from FAdV stock as demonstrated by 
serological tests and virus isolation (Monreal, 1992). Almost all FAdV infected poultry flocks 
are co-infected with AAV; however no information is available on AAV in other bird species or 
in their respective isolates (Monreal, 1992). FAdV and AAV have been considered together due 
to their close association (Monreal, 1992). Fifty percent of FAdV isolated in the USA and 
Ireland contained AAV serologically indistinguishable from the initial isolate (El Mishad et al., 
1975). 
Apparently healthy chickens are also shown to co-infected with FAdV and AAV (Yates 
et al., 1976). The inability to detect AAV from chickens in which FAdV is readily detected may 
be due to low sensitivity, low level of infection or latency (Yates et al., 1976).  AAV is 
dependant on a helper virus for efficient multiplication, and requires the functions provided by 
the co-infecting helper virus, most frequently, FAdV  and also avian herpesviruses contribute 
complete helper activity (Bauer et al., 1986; Tattersall et al., 2005). In the absence of helper 
virus AAV become integrated into the host genome, and in the presence of helper virus AAV 
enter the multiplication cycle (Bauer et al., 1986; Bauer and Monreal, 1986). Latency of AAV 
has also been demonstrated in chicken kidney cell cultures originated from SPF flocks free of 
antibodies against AAV (Dawson et al., 1982). Therefore, AAV is suggested to be a  latent, 
endogenous virus of some flocks of White Leghorn (Dawson et al., 1982; Monreal, 1992) or SPF 
chickens (Sadasiv et al., 1989).  
  50 
Concurrent vertical transmission of FAdV and AAV has also been observed in 
experimental  and natural infections (Dawson et al., 1981). FAdV-1 (CELO virus) and AAV 
have been concurrently isolated from field isolates (Hess et al., 1995). Following inoculation of 
hens with a mixture of FAdV and AAV vertical transmission occurred from 1 to 8 days post 
inoculation, and not from 9 - 16 day, or after re-inoculation 3 months thereafter (Dawson et al., 
1981). In the natural infection, both viruses were isolated for 7 days, and no viruses were isolated 
following a four-fold increase in antibody titers in hens (Dawson et al., 1979). The AAV are 
highly antigenic, and IgM can be detected by AGID one week following AAV and FAdV 
exposure, and this early appearance of AAV IgM could be an early indicator of FAdV infection 
(Dawson et al., 1979; Yates et al., 1979). AAV have also been detected together with FAdV in 
electron microscopic examination of SPF chicken (McFerran et al., 1971)  or monolayer cultures 
derived from SPF chickens (Saifuddin et al., 1992).  
Co-infection of AAV with FAdV in chickens causes a reduction in FAdV pathogenicity; 
and marked inhibition of FAdV replication in cell culture, embryos and chicks (Pronovost et al., 
1978; 1979). Inhibition of multiplication of MDV has been observed in AAV co-infected 
chicken cell culture (Bauer and Monreal, 1988). Cytopathological changes, if caused by AAV, 
are not distinguishable as any specific cell changes are masked by the CPE of the helper virus 
(Monreal, 1992). Electron microscopy and immunofluoresence assay can be used to detect AAV 
in chicken cell cultures (Yates et al., 1973). Latency of AAV has been observed in chicken cell 
cultures (Sadasiv et al., 1989)  
Although the molecular and biological properties of AAV are largely unknown (Bossis 
and Chiorini, 2003), various aspects such as virion properties, biophysical and chemical 
properties, replication and propagation, helper activity, and pathogenesis of AAV have been 
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described, and reviewed (Monreal, 1992). In embryonated eggs AAV could be isolated from 
embryos infected with purified FAdV (Monreal, 1992). 
 
1.9.1. Avian adeno-associated virus as gene delivery vectors in chickens  
Ability to infect both dividing and non-dividing cells, to establish long-term transgene 
expression and the lack of pathogenicity have made AAV attractive for use in gene therapy 
applications (Ponnazhagan et al., 2001; Bossis and Chiorini, 2003). The AAV have been proved 
to be useful as gene delivery vectors in poultry vaccination (Perozo et al., 2008a; Perozo et al., 
2008b). AAV expressing IBDV VP2 gene (Perozo et al., 2008b) and Newcastle disease 
hemagglutin-neuraminidase protein (Perozo et al., 2008a) have been used as novel approaches to 
poultry vaccination against IBD and ND respectively. 
 
1.10. Summary, hypotheses and research objectives 
Inclusion body hepatitis is typically an acute, viral disease in young, 2-7 week old, broiler 
chickens. Outbreaks of IBH are characterized by sudden onset of mortality that can exceed 30% 
with a short clinical course of 4-5 days. The clinical signs include severe depression, ruffled 
feathers and a crouching position. On necropsy the affected birds have pale, swollen, friable, 
hemorrhagic livers with focal to extensive necrosis, and basophilic intranuclear inclusion bodies 
in hepatocytes. 
Five fowl adenovirus (FAdV) species, designated with the letters A-E, are recognized in 
the genus Aviadenovirus within the family Adenoviridae based largely on molecular criteria, in 
particular DNA sequence data. Fowl adenoviruses are further subdivided into twelve serotypes 
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based on the results of cross neutralization tests. Most FAdV are considered non-pathogenic and 
only certain serotypes and genotypes have been associated with IBH outbreaks. It is possible to 
isolate two or even three serotypes of FAdV from a single bird, suggesting that there is little 
cross protection.  
IBH occurs worldwide, often associated with immunosuppressive diseases such as IBDV, 
CAV and reovirus infection. Outbreaks of IBH with 30-40% mortality have occurred in 
Australia, New Zealand, North America and several South American countries.  Studies 
conducted in Canada, USA, New Zealand, and Australia indicated that IBH occurred as a 
primary disease with no association with IBDV or CIAV. Most pathogenicity studies of FAdV 
have been conducted in SPF chicks or immunosuppressed chickens.  
Since 2000, the prevalence of IBH in Canada has increased. Outbreaks associated with FAdV-2, 
FAdV x11a-like virus, FAdV-8a strain TR-59 and strain T8-A and FAdV-11 strain 1047 resulted 
in mortality of up to 30%. The hypotheses of this study were: 
1. IBH is a vertically-transmitted primary disease in commercial broilers. 
2. IBH in broilers can be prevented by vaccinating their parents.  
 
The objectives of this study were: 
1. Development of an animal model of IBH in commercial broilers.  
2. Demonstration of vertical transmission of FAdVs from broiler breeders to their 
progeny. 
3. Prevention of IBH in commercial broilers by vaccinating of their parents with an 
inactivated FAdV vaccine.    
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2.0. INCLUSION BODY HEPATITIS AS A VERTICALLY-TRANSMITTED PRIMARY 
DISEASE IN BROILER CHICKENS1
2.1. Abstract 
, 2, 3 
In the last few years, inclusion body hepatitis (IBH) has emerged as an economically 
important disease in broilers in Canada. Historically, infections with IBDV and CIAV have been 
shown to suppress the immune system of broilers and make them more susceptible to a 
secondary disease such as IBH. Recently, we reported that virulent FAdV are able to cause IBH 
as a primary disease in broilers without apparent involvement of IBDV and/or CIAV based on 
serological evidence. The objectives of the present study were to experimentally reproduce IBH 
in commercial broiler chickens and demonstrate vertical transmission of FAdV from broiler 
breeders to their progeny. Fourteen-day old broilers were inoculated intramuscularly with 1x104 
– 1x107 CCID50 of FAdV x11a-like virus; two strains of FAdV-8a (FAdV-8a strain TR-59, and 
FAdV-8a strain T8-A); and FAdV-11 strain 1047. Four days following FAdV inoculation, 5% - 
15% mortality was observed with histological lesions of hemorrhagic necrotizing hepatitis. To 
demonstrate vertical transmission of the FAdV, 35-week-old broiler breeders were inoculated 
with 1x106 CCID50 of FAdV x11a-like virus, FAdV-8a strain TR-59, FAdV-8a strain T8-A, and 
FAdV-11 strain 1047. Eggs from infected breeders were collected and hatched seven days post-
inoculation. Clinical signs or mortality were not observed in parents. In contrast, broiler progeny 
derived from broiler breeders inoculated with FAdV-8a strain T8-A had 30% IBH mortality by 
seven days of age. The hexon gene loop 1 sequence of the virus isolated from affected broiler 
progeny showed 100% identity to FAdV-8a strain T8-A. The results of this study supports the  
                                                 
1 Submitted to Avian Diseases (Ekanayake et al., 2009; 2presented at the 145th American Veterinary Medical  
Association Annual Convention (Ekanayake et al., 2008), and 3146th American veterinary Medical Association 
Annual Convention (Gomis et al., 2009) 
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hypothesis that IBH in broilers in Canada is a vertically-transmitted primary disease with no 
known immunosuppressive involvement (Ekanayake et al., 2008; Ekanayake et al., 2009; Gomis 
et al., 2009). To the best of our knowledge, this is the first report to demonstrate vertical 
transmission of FAdV by virus isolation in commercial broiler chickens following experimental 
FAdV inoculation of broiler breeder parents. 
 
2.2. Introduction  
Inclusion body hepatitis (IBH) is typically an acute, viral disease in young,  2 - 7 week 
old broiler chickens (Adair and Fitzgerald, 2008). Outbreaks of IBH are characterized by sudden 
onset of mortality that can exceed 30% (Christensen and Saifuddin, 1989) with a short clinical 
course of 4-5 days (Adair and Fitzgerald, 2008). The clinical signs include severe depression, 
ruffled feathers and a crouching position. On necropsy the affected birds have pale, swollen, 
friable, hemorrhagic livers with focal to extensive necrosis, and basophilic INIB in hepatocytes 
(Adair and Fitzgerald, 2008). 
Five FAdV species, designated with the letters A-E, are recognized in the genus 
Aviadenovirus within the family Adenoviridae based largely on molecular criteria, in particular 
DNA sequence data (Benko et al., 2005). Fowl adenoviruses are further subdivided into twelve 
serotypes based on the results of cross neutralization tests (Cowen et al., 1977). Most FAdV are 
considered non-pathogenic and only certain serotypes and genotypes have been associated with 
IBH outbreaks. It is possible to isolate two or even three serotypes of FAdV from a single bird, 
suggesting that there is little cross protection (McFerran and Smyth, 2000).  
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IBH occurs worldwide, often associated with immunosuppressive diseases such as IBDV, 
CIAV and reovirus infection (Rosenberger et al., 1975; Fadly et al., 1976; Grimes et al., 1978a). 
Immunosuppressive effects of FAdV isolates associated with IBH also have been observed 
(Saifuddin, 1992; Schonewille et al., 2008). Outbreaks of IBH with 30-40% mortality have 
occurred in Australia, New Zealand, North America and several South American countries 
(Christensen and Saifuddin, 1989; Grimes, 1992; Zavala et al., 2002; Gomis et al., 2006; 
Grimes, 2007).  Studies conducted in Canada, USA, New Zealand, and Australia indicated that 
IBH occurred as a primary disease with no association with IBDV, CIAV or avian leukosis virus 
J subtype (McCracken et al., 1976; Grimes et al., 1978a; El-Attrache and Villegas, 2001; Zavala 
et al., 2002).  
Most pathogenicity studies of FAdV have been conducted in SPF chicks (Toro et al., 
2000; Nakamura et al., 2003b) or immunosuppressed chickens (Saifuddin and Wilks, 1990b). 
Reproduction of IBH in 2-day-old, conventionally raised broilers resulted in 30% and 45% 
mortality with oral and intraperitoneal routes of inoculation, respectively (Barr and Scott, 1988; 
Erny et al., 1991). The minimum lethal dose of virulent FAdVs varied from 4 TCID50  to more 
than 1x106 TCID50 (Barr and Scott, 1988; Okuda et al., 2001), and some experiments used even 
high-titer inoculums (Grimes and King, 1977b). Some studies attributed the inability to 
experimentally reproduce IBH to the presence of neutralizing Ab (Cook, 1974). These results 
showed a wide variability in pathogenesis and severity since these studies have used different 
susceptible ages, routes of infection, virus serotypes and strains (Toro et al., 1999; Zavala et al., 
2002). The inability to reproduce the disease has led to uncertainty about the role of 
immunosuppressive agents to induce clinical disease in broiler chickens (Cook, 1983) or age 
related-resistance to FAdV infection (Gomis et al., 2006; Ojkic et al., 2008b). 
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Since 2000, the prevalence of IBH in Canada has increased, and several FAdV serotypes, 
namely, FAdV x11a-like virus, FAdV-8a strain TR-59 and strain T8-A or FAdV-11 strain 1047 
have been responsible for IBH outbreaks with motralities up to 30 % (Gomis et al., 2006; Ojkic 
et al., 2008a; Ojkic et al., 2008b). Occurrence of IBH in broilers in Saskatchewan, Canada has 
been observed as a primary disease with no apparent association with immunosuppressive 
diseases such as IBD and CIA (Gomis et al., 2006).  
 
2.3. Materials and methods 
 2.3.1. Inclusion body hepatitis animal model development in 14-day-old broiler chickens  
All procedures with animals were conducted according to protocols that were approved 
by the Animal Care Committee, University of Saskatchewan in accordance with Canadian 
Council on Animal Care (Canadian Council on Animal Care, 1993). Two hundred and sixty four 
day-old broiler chickens were obtained from a local hatchery in Saskatchewan, identified 
individually by neck tags (Swiftack Poultry Tags, Heartland Animal Health Inc., MO), randomly 
divided into groups and located in the Animal Care Unit, Western College of Veterinary 
Medicine, University of Saskatchewan, Canada. Water and commercial broiler rations were 
provided ad libitum and placed on kiln-dried wood shaving bedding.  Air from each room was 
exhausted through a HEPA filter and replaced with non-recirculated intake air at a rate of 18 
changes/h. Air pressure differentials and strict sanitation were maintained in this isolation 
facility. Photoperiods of 24 h per day for the first 3 days and 16 h per day for the remaining 23 
days were established. Room temperature was maintained at 30 - 32 0C for the first week and 28-
300C for the remaining duration of the animal experiment.  
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Birds were observed for clinical signs thrice daily for 12 days following FAdV challenge. 
Daily clinical scores for individual birds were recorded as follows: 0 = normal; 1= hesitate to 
move and tire quickly; 2 = unable to stand or forage for food and euthanized; 3 = dead. Mortality 
was counted each day. Dead or euthanized birds were necropsied immediately. Parent flocks of 
these broiler chickens were vaccinated against IBD at 2 weeks (Clonevac D-78: Intervet Canada 
Ltd., Ontario, Canada), 8 weeks (Bursa BlenM; Merial Canada Ltd., Quebec, Canada), and 18 
weeks (Breedervac IV Plus, Intervet Canada Ltd., Ontario, Canada) and against CAV at 18 
weeks (CAV-Vac; Intervet Canada Ltd., Ontario, Canada).  
Fourteen-day-old broiler chickens were randomly allocated into 33 groups (32 treatment 
groups and 1 control group) (Table 2.1.), each containing 8 birds. Groups of chickens were 
inoculated intramuscularly with 1x104, 1x105, 1x106 or 1x107 CCID50 of FAdV in the left thigh 
as follows: (a) chicken embryo liver (CEL) grown FAdV x11a-like virus, FAdV-8a strain TR-59, 
FAdV-8a strain T8-A or FAdV-11 strain 1047; (b) purified liver homogenate (LH) of FAdV 
from clinical cases of IBH, FAdV x11a-like virus, FAdV-8a strain TR-59, FAdV-8a strain T8-A 
or FAdV-11 strain 1047; (c) saline (pH 7.4). Following FAdV or saline inoculation, chickens 
were to maintain the same environmental and management practices and observed for 12 days 
for clinical signs and mortality. At 13 day post-challenge, the remaining birds were euthanized 
and necropsied.  
 
2.3.2. Histology and transmission electron microscopy 
Tissue sections from the liver, pancreas and lymphoid organs were fixed in 10% neutral 
buffered formalin, embedded in paraffin, sectioned at 5 μm thicknesses and stained with H&E 
for histopathological studies. Tissue sections from the liver and pancreas were fixed in 5% 
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glutaldehyde in sodium cocodylate buffer (Marivac, Quebec, Canada; pH 7.2) for 24 h at 40C, 
post-fixed in 1% osmium tetroxide in cocodylate buffer (Electron Microscopy Sciences, PA) for 
1 h, dehydrated serially in 50, 70, 90 and 95% ethyl alcohol for 30 min. at each concentration 
followed by 100% for 1 h. The sections were placed in 1:1 propylene oxide: epon gradually 
embedded and polymerized at 60 0C. Ultra-thin sections were cut, stained with 2% uranyl acetate 
and 0.5% lead citrate (Electron Microscopy Sciences, PA), mounted on 200-mesh copper grid 
(Electron Microscopy Sciences, PA) and examined under a Phillips EM-200 transmission 
electron microscope (Phillips Company, Eindhoven, Holland) operated at 60 kV. 
 
2.3.3. Demonstration of vertical transmission of FAdV from broiler breeders to their 
progeny 
Sixteen, 20-week-old broiler breeders were obtained from a local broiler breeder 
producer in Saskatchewan and maintained at the Animal Care Unit, Western College of 
Veterinary Medicine, University of Saskatchewan, Canada. A lighting program and feeding of 
broiler breeders were implemented according to the guidelines for Ross Broiler Breeders 
(Aviagen™ Inc., AL). Thirty-five week old broiler breeders were divided into four groups, each 
group containing three females. Birds were inoculated with 1x107 (CCID50) FAdV x11a-like 
virus, FAdV-8a strain TR-59, FAdV-8a strain T8-A or FAdV-11 strain 1047 isolated from 
clinical cases of IBH. Each group was introduced to a male broiler breeder. Males were 
inoculated with FAdV x11a-like virus or FAdV-8a strain T8-A in respective groups and males 
were not inoculated with FAdV in the remaining two groups. For seven days post- inoculation of 
the parent breeders, eggs were collected and incubated until hatched. Ten broiler chicks were 
observed for three weeks post-hatch for clinical signs and mortality. Additionally, 10 broiler 
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chicks were euthanized immediately after hatch and tissue samples were collected for FAdV and 
AAV isolation. Furthermore, 20 eggs were collected from each group for 7 days at the beginning 
of the 36th and 37th-week, and chicks were observed for three weeks post-hatch. Broiler breeders 
were vaccinated against IBD at 2 weeks (Clonevac D-78: Intervet Canada Ltd., Ontario, 
Canada), 8 weeks (Bursa BlenM; Merial Canada Ltd., Quebec, Canada), and 18 weeks 
(Breedervac IV Plus, Intervet Canada Ltd., Ontario, Canada) and against CAV at 18 weeks 
(CAV-Vac; Intervet Canada Ltd., Ontario, Canada). 
 
2.3.4. Virus propagation, isolation and cell culture methods 
 2.3.4.1. Virus isolation in Leghorn male hepatoma cell line 
Virus isolation was conducted in Leghorn male hepatoma (LMH) cell line obtained from 
American Type Culture Collection (ATCC#CRL-2117, VA) and maintained as described 
(Kawaguchi et al., 1987). The LMH cells were propagated in Waymouth’s MB 752/1 medium 
(1X) (Invitrogen Corporation, Auckland, NZ) supplemented with 10% fetal bovine serum, L-
glutamine 200 mM / ml and 10 µl/ml gentamicin (Invitrogen Corporation, Auckland, NZ) in 75 
cm2 collagen-coated tissue culture flasks (Becton Dickinson, Bedford, MA, UK) as described 
previuosly (Schat and Sellers, 2008). Liver samples from 23 different IBH outbreaks were 
obtained during 2005 and 2006. Pooled liver samples from each barn  were identified as FAdV 
x11a-like virus, FAdV-8a strain TR-59, FAdV-8a strain T-8A (showed same percentage identity 
to both  FAdV-8a strain T-8A and FAdV-8b strain 764) or FAdV-11 strain 1047 by sequencing 
and phylogenetic analysis at the Animal Health Laboratory, University of Guelph. Ten percent 
liver suspensions in Waymouth’s MB 752/1 medium were inoculated at a multiplicity of 
infection (m.o.i.) of 1 to 80% confluent LMH cells and incubated for 1 h at 37 0C. The remaining 
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inoculum was washed 3 times with sterile phosphate-buffered saline (PBS) (pH 7.4) and 
incubated in 5% CO2 and 85% humidity for 1 week or until a CPE was observed. Samples were 
considered negative if CPE was not observed after the second passage.  
Animal challenge inoculums of FAdV liver homogenates (LHs) were prepared as 
follows. Ten percent liver suspensions were prepared in Waymouth’s MB 752/1 medium (1X) 
(Invitrogen Corporation, Auckland, NZ) by homogenizing at 1000 rpm for 30 min (Polytron PT 
3000, Kinematica, AG, Littau, Switzland). The suspensions were subjected to 6 cycles of freeze-
thaw followed by centrifuging at 6000 rpm using a fixed-angle JA-10 rotor (Beckman Coulter, 
Inc., CA) for 30 min at 4 0C. The supernatant was filtered through 5 µm and 2 µm pore-sized; 25 
mm diameter-syringe filters (Millipore Ireland BV, Cork, Ireland) to remove debris. Finally, the 
suspensions were filtered through 0.45 µm  and 0.22 µm pore-sized filters (Millipore Ireland BV, 
Cork, Ireland)  to purify FAdV (Davis et al., 1995; Davis et al., 1996) and stored at -80 0C until 
used for animal inoculation described in 2.3.1. Uninoculated control group (n=8) was injected 
with 0.1 ml saline (pH = 7.4) intramuscularly. 
 
2.3.4.2. Preperation of chick embryo cell culture    
Chick embryo liver cell cultures were prepared from livers obtained from nine-day-old 
SPF chickens (Charles River Laboratories, CT). Livers were washed three times with sterile 
phosphate buffered saline; gall bladders were removed and chopped with crossed scalpels. Then, 
20 ml of  0.5% trypsin + 5.3 mM ethylene diamine tetra acetic acid (Corporation,  Auckland, 
NZ), 30 ml of sterile PBS, 10, 000 IU/ml penicillin G and streptomycin 10, 000 mg/ml were 
prewarmed (37 0C), added and incubated at 37 0C for 5 min. with vigorous intermittent shaking. 
The supernatant was filtered through double-layered sterile cheese cloth and centrifuged at 2000 
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rpm at 4 0C for 5 min. The pellet was resuspended at 1: 400 ratio in Dulbecoo’s Modified Eagle 
Medium with nutrient mixture F-12 (Ham) 1X (DMEM / F12 (1:1) (Invitrogen Corporation, 
Auckland, NZ) supplemented with 5 % fetal bovine serum,  10,000 IU / ml penicillin G and 
streptomycin 10, 000 mg / ml (Invitrogen, Auckland, NZ) by repeated gentle pipetting.   
CEL cell suspension in DMEM / F 12 (1:1) (Invitrogen Corporation, Auckland, NZ) 
supplemented with 5% fetal bovine serum, penicillin G 10, 000 IU / ml and streptomycin 
sulphate 10, 000 µg / ml (Invitrogen Corporation, Auckland, NZ) were seeded at 2x106 / ml in 75 
cm2  collagen-coated tissue culture flask (Becton Dickinson, Bedford, MA, UK) and incubated in 
5% CO2 and 85% humidity at 37 0C to form confluent monolayers in 24 h. 
 
2.3.4.3. Cell culture count  
CEL cell suspension (prepared in 2.3.4.2.) is mixed thoroughly and mixed with 0.4% 
trypan blue in 0.85% saline (Invitrogen Corporation, Auckland, NZ) at 1:1 ratio and allow to 
stand for 15 min. Counting chambers of a improved Neubeuer hematocytometer (Bright-Line 
hemocytometer, 1/10 mm deep, Hausser Scientific Horsham, PA) is filled gently with the 
mixture and covered with a cover slip. The unstained cells in large squares (4 corners + 1 center) 
on each side of the counting chamber are counted at 100 times magnification under the light 
microscope. The number of viable cells in each side of the counting chamber was determined by 
multiplying the number of viable cells counted chamber conversion factor and dilution factor, 
then dividing by the number of squares counted to obtain the cell count per milliliter.  
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2.3.4.4. Virus isolation in chick embryo liver cells 
Confluent CEL cell cultures were infected individually with LH (prepared in 2.3.4.1.) at 
1 m.o.i.  at 37 0C for 1 h and remaining inoculum was washed 3 times with sterile PBS (pH 7.4), 
added  and incubated in 5 % CO2  and 85 % humidity for 5 days or until a CPE is observed. 
Samples were considered negative if CPE was not observed after the second passage. When 
maximum CPE was observed, cell cultures were harvested and subjected to 6 cycles of freeze-
thaw followed by centrifugation at 2000 rpm for 10 min. at 40C. The supernatant were filtered 
through syringe filters with porosity of 0.45 µm (Millipore Ireland BV, Cork, Ireland) and stored 
at – 80 0C until used for animal inoculation described in 2.3.1. 
 
2.3.4.5. Virus titration 
The FAdV in LH and those propagated in CEL were titrated by end point dilution assay 
as described previously (Villegas, 2008). Briefly, ten-fold serial dilutions of LH or CEL 
propagated FAdV in Waymouth’s MB 752/1 medium (1X) were inoculated to 80% confluent 
LMH cells in collagen-coated 96-well, flat-bottom microtiter plates, and incubated at 37 0C for 1 
h. The remaining inoculum was washed once with Waymouth’s MB 752/1 medium and filled 
with Waymouth’s MB 752/1 (1X) supplemented with 10 % fetal bovine serum, gentamicin 10 
mg / ml and incubated in 5% CO2 at 37 0C. The plates were observed daily under 20 
magnification of an inverted microscope (Olympus CKX 41, Olympus Corporation, Japan) for 
CPE. The proportionate distance (PD) between adjacent dilutions is calculated by percentage 
infected at dilution next above 50% minus 50% divided by percentage infected at dilution next 
above 50% minus percentage infected at dilution next below 50%. The 50% end point was 
calculated by the formula:  log of the 50% end point = (log dilution above 50% - (PD x log 
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dilution factor) and TCID50 in LMH cell line expressed as positive exponential with one decimal 
point mililiter. 
 
2.3.5. Sequencing and genotyping  
The L1 region of the FAdV hexon protein gene was amplified by PCR as described 
previously (Ojkic et al., 2008b). Nucleotide sequences of PCR products were determined at the 
Laboratory Services, Molecular Supercentre, University of Guelph. Sequence editing and 
phylogenetic analysis were done by using the LaserGene software package (DNAStar, Inc., 
Madison, WI). The amino acid sequence of the variable region of L1 was determined and 
analyzed.  A 158 amino acid sequence from residues 130 to 287, based on the FAdV-9 hexon 
gene sequence, was used to calculate sequence identities and construct phylogenetic trees. 
 
2.3.6. Statistical analysis 
Survival data were analyzed by Chi-square test using Student edition of Statistix 7 
(Analytical Software, Tallahassee, FL) for heterogenecity or independence in various doses (104 
– 107) and virus preparations (LH and CEL). A P value <0.05 was considered significant. The 
graphic display was done with GraphPad PRISM 4.0 (GraphPad Software, Inc., San Diego, CA). 
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2.4. Results 
 2.4.1. Inclusion body hepatitis animal model development in 14-day-old broiler chickens 
 
The IBH mortality for each FAdV serotype was calculated as a percentage of IBH deaths. 
The mortality associated with different serotypes of FAdV varied from 5-15%. Birds inoculated 
with either FAdV-8a strain TR-59 or FAdV-11 strain 1047 demonstrated 5% mortality. In 
contrast, chickens inoculated with either FAdV-8a strain T8-A or FAdV x11a-like virus 
demonstrated 15% mortality (Figure 2.2.). The groups inoculated with LH showed a trend 
toward greater motrailty than the CEL inoculated groups (P = 0.0581, degree of freedom 1, 
overall Chi-square 3.59) (Table 2.1.). Various virus doses did not have an effect on the mortality 
(P = 0.67, degree of freedom 3, overall Chi-square 1.55). There was a significant effect of 
serotypes on the mortality (P = 0.018, degree of freedom 3, overall Chi-square 10.06). Birds that 
died or were euthanized had necrotizing, hemorrhagic hepatitis with basophilic INIB (Figures.  
2.2. A, B). Some birds had necrotizing pancreatitis with INIB (Figures 2.2. B, D). Electron 
microscopic examination revealed non-enveloped, hexagonal shape viral particles measuring 70-
90 nm in crystalline arrays in nuclei of hepatocytes (Figure 2.2. E), and dispersed, but confined 
to the nucleus of pancreatic acinar cells (Figure 2.2. F). A few birds that died of IBH had diffuse 
yellow discoloration of the body fat and focal to extensive hemorrhages in the proventriculus.  
Although birds were commingled, the respective genotype of FAdV was isolated from 
IBH infected livers corresponding to their challenge FAdV inoculums. Clinical signs were 
observed only in birds that developed gross lesions of IBH. All the birds that did not develop 
clinical IBH remained clinically normal until the end of the experiment and did not demonstrate 
any gross lesions at necropsy. 
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Table 2.1. Mortality of broilers inoculated with various doses of FAdV propagated in chicken 
embryo liver and liver homogenate of clinical cases of IBH. 
[LH = liver homogenate, CEL = chicken embryo liver, Control = saline] (n = 8)       
 
FAdV 
preparation 
Dose 
TCID50 
FAdV  x11a-
like virus 
FAdV-8a 
strain TR-59 
FAdV-8a 
strain T8-A 
FAdV-11 
strain 1047 
LH 1x104 1/8 0/8 5/8 0/8 
1x105 2/8 1/8 1/8 1/8 
1x106 1/8 1/8 2/8 0/8 
1x107 2/8 0/8 0/8 0/8 
CEL 1x104 1/8 0/8 0/8 0/8 
1x105 0/8 0/8 0/8 1/8 
1x106 2/8 0/8 2/8 0/8 
1x107 1/8 1/8 0/8 0/8 
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Figure 2.1. Mortality of groups of 14-day-old commercial broiler chickens following inoculation 
with FAdV. FAdV x11a-like virus (▲), FAdV -8a strain TR-59 (●), FAdV-8a strain T8-A (○), 
FAdV-11 strain 1047 (▼) or saline (■). Birds were inoculated with either FAdV-8a strain TR-59 
or FAdV-11 strain 1047 demonstrated 5% mortality; in contrast, birds were inoculated with 
either FAdV-8a strain T8-A or FAdV x11a-like virus demonstrated 15% mortality (n = 64). All 
FAdV inoculated groups had significantly lower survival when compared to saline injected 
chickens (control), (P = 0.018) 
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Figure 2.2. Gross, microscopic and electron microscopic lesions of IBH affected chicken. 
The liver is swollen; with diffuse hemorrhagic and necrotizing foci due to FAdV infection (A) 
the pancreas had multifocal hemorrhagic necrotizing foci (B). Dark blue areas (arrow) 
demonstrate INIB due to FAdV replication in hepatocytes, (H&E), bar = 100 µm (C) and 
pancreatic acinar cells, (H&E), bar = 100 µm (D). Electron microscopic demonstration of 
adenoviruses in the nucleus of an IBH infected hepatocyte, bar = 2500 nm, (uranyl acetate/lead 
citrate), Inset: higher magnification of the virus, bar = 500 nm, (uranyl acetate/lead citrate) (E) 
and pancreatic acinar cell, bar =2µm, (uranyl acetate.lead citrate) (F). 
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2.4.2. Demonstration of vertical transmission of adenoviruses from broiler breeders to their 
progeny 
 Clinical signs of IBH or mortality were not observed in broiler breeders. Broilers hatched 
from the eggs collected from breeders during 1–7-day post- FAdV-8a strain T8-A inoculation 
reproduced the clinical IBH in 30% (3 of 10 birds) of broilers at 6-7 days post-hatch. Broilers 
that died with clinical IBH had hemorrhagic, necrotizing hepatitis with basophilic INIB.  The 
pancreas had multifocal necrotizing pancreatitis with INIB. The remaining seven of ten birds 
from FAdV-8a strain T8-A inoculated parents did not develop any clinical signs of IBH during 
the experiment. [FAdV-8a strain T8-A was confirmed by virus isolation or PCR (Table 2.2)].  
Further, FAdV-8a strain T8-A was isolated from liver, spleen and bursa of Fabricius from all 
three birds that died of IBH (Table 2.2.). FAdV was isolated from the liver from one of the seven 
clinically normal birds at the termination of the experiment (Table 2.2.). No FAdV was isolated 
from the liver samples of another group of ten birds originating from FAdV-8a strain T8-A 
inoculated parents at the time of hatch (Table 2.2.). In contrast, FAdV-8a strain T8-A was 
isolated from the spleen, yolk sac and bursa of Fabricius from five of the same ten birds (Table 
2.2.). No AAV was detected in any of the birds that FAdV was isolated. No clinical signs or IBH 
were observed in any of the broilers from broiler breeder parents inoculated with FAdV x11a-
like virus, FAdV-8a strain TR-59, or FAdV-11 strain 1047 during the entire duration of the 
experiment. None of the broiler progeny derived from eggs collected at week 36 or 37 developed 
any clinical signs or IBH during the three week post-hatch period. 
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Table 2.2. Fowl adenovirus isolation in the broiler progeny derived from broiler breeders 
inoculated with FAdV-8a strain T8-A 
 
*yolk sac is absorbed at that age 
 Liver Spleen Bursa of 
Fabricius 
Yolk sac 
Day 1 0/10 4/10 4/10 5/10 
Day 6-7 3/3 3/3 3/3 * 
Day 21 1/7 0/7 0/7 * 
  71 
 2.5. Discussion 
Historically, IBH was generally considered a secondary disease in broiler associated with 
primary immunosuppression following infection with IBDV (Neumann et al., 1987) or CIAV 
(Rosenberger et al., 1975; Fadly et al., 1976). Under these circumstances, immunosuppressed 
birds exposed to FAdV from the environment would eventually develop a clinical disease.  IBH 
has also been occasionally described as a primary disease causing economic losses in the broiler 
industry without prior immunosuppression (Rosenberger et al., 1974; Toro et al., 2000). Further, 
it was often suggested that vertical transmission of FAdVs from broiler breeders caused the 
clinical disease of IBH in their progeny (Grgic et al., 2006). It has also been demonstrated that 
vaccination against IBH and IBH/HPS in broiler breeders controlled vertical transmission of 
FAdV (Toro et al., 2000; Toro et al., 2001b). 
The objective of this study was to examine if IBH is a primary disease in commercial 
broiler chickens. Antibody levels against IBDV and CIAV were high in broiler breeders due to 
vaccinations against IBDV and CIAV and hence, their progeny had the expected level of 
maternal Ab against IBDV and CIAV at hatch. Clinical IBH with necrotizing, hemorrhagic 
lesions and INIB in the liver were seen in all dead or clinically diseased euthanized birds 
following challenge with FAdV. Mortality was 15% in groups challenged with FAdV x11a-like 
virus or FAdV-8a strain T8-A; in contrast, mortality was 5% in birds challenged with FAdV-8a 
strain TR-59 or FAdV-11 strain 1047. The difference in mortality in groups infected with 
different IBH genotypes could be associated with the virulence of different strains of FAdV. In a 
few birds, necrotizing pancreatitis with INIB was evident as shown in previous studies (Grimes, 
1992; Toro et al., 2001a; Grimes, 2007). The mortality and the clinical disease of IBH were 
caused by as low as 1x104 TCID50 to high as 1x107 TCID50 of FAdV. Also, IBH was caused by 
  72 
both CEL cell culture-grown FAdV, and FAdV isolated from clinical cases of IBH. Although all 
the experimental groups were commingled during the entire experiment, there was no evidence 
of horizontal transmission of adenoviruses between the groups since the corresponding group 
challenge genotype of adenovirus was isolated from each of the bird each group. 
Although, there were several attempts made previously to demonstrate vertical 
transmission of FAdV in broiler chickens (Grgic et al., 2006; Philippe et al., 2007), this is the 
first demonstration of vertical transmission of FAdV-8a strain T8-A by virus isolation in 
commercial broiler chickens following FAdV inoculation of their parents. This observation was 
confirmed by isolating FAdV-8a strain T8-A in the liver of IBH infected birds corresponding 
with the challenge inoculums of their parents. Also FAdV-8a strain T8-A was isolated from the 
spleen and bursa of Fabricius of these birds. Although, we were able to demonstrate vertical 
transmission of FAdV-8a strain T8-A only in the progeny from eggs collected for seven days 
following experimental inoculation, it is necessary to further study the duration of vertical 
transmission of FAdV-8a strain T8-A in broiler breeder parents to better understand the duration 
of virus shedding into the eggs. Further, we were not able to demonstrate vertical transmission of 
FAdV x11a-like virus, FAdV-8a strain TR-59 or FAdV-11 strain 1047, but it may be due to the 
small sample size, that we study or interference of VN Ab against IBH in breeders. It will be 
necessary to have larger groups of experimentally infected broiler breeders and their resulting 
progeny to confirm the results of these serotypes in this study. It is necessary to study VN Ab in 
commercial broiler breeders in order to understand the effect of VN Ab of FAdV on vertical 
transmission. It is interesting to note that FAdV-8a strain T8-A was not present in the liver by 
virus isolation or PCR at the time of hatch although virus was isolated from the spleen, bursa of 
Fabricius and yolk sac of the bird at hatch and this could be related to particular, but unknown, 
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interactions of FAdV and the immune response of neonatal broiler chickens. Although we were 
able to isolate FAdV from the spleen, yolk sac and bursa of Fabricius immediately after hatch 
with no clinical disease, further studies are necessary to understand FAdV replication, organ 
predilection, and immune mechanisms at the time of hatch in order to understand host-pathogen 
interactions associated with development of liver lesions together with clinical IBH seen in older 
chicks. Latent adenovirus  infections in tonsil and adenoid tissues of humans have been 
described (Neumann et al., 1987; Philippe et al., 2005; Grgic et al., 2006) ; and a similar 
establishment is suggested in chickens (Neumann et al., 1987). The presence of FAdV in spleen, 
bursa of Fabricius or yolk sac may be associated with adenoviral latency in broiler chickens and 
needs to be investigated. Experimental vertical transmission of FAdV was seen in day-7 post-
hatch broilers and this is compatible with data from an IBH field study conducted in Canada 
where clinical IBH was reported to range from 7 - 91 days of age (Nagy, 2007; Ojkic et al., 
2008b) . 
In conclusion, this study demonstrated IBH is likely a vertically-transmitted primary 
disease in broiler chickens without apparent immunosuppression. In order to understand 
mechanisms associated with vertical transmission of FAdV in broiler breeders, it is necessary to 
study the expression of immune regulatory genes and cytokine profiles of broiler breeder parents 
and neonatal broiler chickens. Currently, there is no commercial vaccine available in Canada to 
control vertically-transmitted primary IBH in broiler chickens, but pathogenic FAdV genotypes 
identified in this study provide the basis for candidate viruses for the development of a vaccine 
against IBH. 
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3.0. CONTROL OF INCLUSION BODY HEPATITIS IN BROILER CHICKENS BY 
VACCINATING THEIR PARENTS WITH INACTIVATED ADENOVIRUSES  
3.1. Abstract 
Inclusion body hepatitis (IBH) is an emerging, economically important viral disease of 2 
- 7 weeks old broiler chickens. The objective of this study was to prevent IBH in broiler chickens 
by vaccinating their parents with a vaccine containing inactivated FAdV Ag formulated with 
O/W emulsion as an adjuvant.  Four groups of broilers breeders were vaccinated with either 
FAdV-8a strain T8-A (2x107 or 2x104 CCID50) formulated with 20% O/W or FAdV strain x11a-
like virus (2x107 or 2x104 CCID50) formulated with 20% O/W emulsion at the age of 12 and 15 
week. The control group received the adjuvant. Eggs were collected and incubated until hatched 
for challenge protection studies. Broiler progeny were challenged with FAdV-8a strain T8-A at a 
dose of 1x107 TCID50 to study both homologous and heterologous immunoprotective effect of 
the vaccine.  Although, survival of broiler chickens following FAdV-8a strain T8-A challenge 
was not significantly different among vaccinated and non-vaccinated groups (p>0.05), 
immunoprotection was enhanced by increased dose of FAdV-8a strain T8-A Ag in the vaccine. 
Broiler progeny from the parents received a high dose of Ag had a better protection against 
homologous or heterologous challenge.  Further studies are necessary to optimize the 
formulation of FAdV-8a strain T8-A with O/W emulsion or vaccination strategy to improve the 
utility of this FAdV vaccine in the poultry industry.    
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3.2. Introduction 
 Inclusion body hepatitis (IBH) is an economically important, acute viral disease of 2 - 7 
week old broiler chickens caused by several serotypes of FAdVs (Adair and Fitzgerald, 2008). It 
is characterized by a sudden onset of mortality with acute, necrotizing hepatitis containing 
basophilic, INIB in hepatocytes (Adair and Fitzgerald, 2008). Vertical transmission or 
reactivation of latent virus has been identified as an important mode of transmission of FAdV 
(Adair and Fitzgerald, 2008). It is also possible that virulent FAdV are transmitted vertically 
from immunologically naïve hens infected during laying (Adair and Fitzgerald, 2008; Symth and 
McNulty, 2008) or prior to  laying (Grimes, 1992). In broiler breeders, seroconversion and 
development of neutralizing Ab prior to commencement of laying is achieved through 
vaccination (Monreal, 1992; Ojkic and Nagy, 2003), and can prevent the vertical transmission of 
FAdV and subsequent IBH in the progeny (Guittet et al., 1997; Cserep, 2008). 
One of the key contributing factors helping expansion of the poultry industry is control of 
economically important diseases by vaccination (Nagy, 2007). However, despite efficient 
vaccination and superior management practices, particularly in chicken, several diseases such as 
highly pathogenic avian influenza, Marek’s disease, infectious laryngeotrachitis, inclusion body 
hepatitis and inclusion body hepatitis/hydropericardium syndrome have been occurring as 
emerging or re-emerging problems in different regions of the world, and novel vaccines and 
modification of vaccination strategies may be beneficial in controlling these diseases (Guittet et 
al., 1997).  
Poultry vaccines are typically categorized either live or inactivated vaccines; and are 
widely administered via musocal, parenteral or in ovo delivery methods to prevent or reduce 
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several viral, bacterial and coccidial diseases (Saif, 2008; Jones, 2009). Priming the immune 
system with live vaccines followed by boosting with killed vaccines is common in the poultry 
industry  with good results against common poultry disease such as  ND and IBD (Bermudez, 
2008).  
Inactivated vaccines do not result in vaccine-associated disease outbreaks or reversion of 
vaccinal Ag to virulence (Mutalib, 1991). They are used as whole killed viruses or bacterins 
formulated with immunoenhancing substances or adjuvants (Jansen et al., 2007; Bermudez, 
2008; Schijns et al., 2008). Common vaccine adjuvants in the poultry industry are W/O or O/W 
base preparations (Jansen et al., 2007) . The protein Ag of inactivated vaccines are recognized by 
B and/or T cells, and determine the specificity of the immune response (Jansen et al., 2007), 
while the adjuvant determines most other immunopotentiator effects such as magnitude, quality, 
and type of immune response as well as the local or systemic tissue responses (Schijns et al., 
2008).  
Vaccination of breeder chickens is aimed at preventing vertical transmission of certain 
viruses or providing sufficient passive immunity in their progeny (Guittet, 1997). This 
vaccination strategy aims to prevent both vertically- and horizontally-transmitted diseases. These 
aspects are critical as neonatal chickens are highly susceptible to diseases due to immaturity of 
the immune system (Horzinek et al., 1997; Aucouturier et al., 2001). In Canada, breeder 
chickens are vaccinated against several common viral diseases such as ND, IBD, CIAV, and MD 
(Guittet et al., 1997). Inactivated, oil-emulsion vaccines in broiler breeder chickens have been 
shown to elicit high levels of neutralizing Ab and protects progeny against ND (Eidson et al., 
1980; Schijns et al., 2008), IBD (Wyeth et al., 1981). The same strategy has also been adapted to 
control vertically-transmitted diseases such as HPS/IBH (Gough et al., 1981) and EDS (Schijns 
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et al., 2008). In Australia, vaccination of broiler breeder chickens with a commercial, chick 
embryo liver-grown live vaccine containing a virulent strain of FAdV-8b at 1x104 TCID50/dose 
has been used to control IBH successfully (Grimes, 1992; 2007). In USA, autogenous, 
inactivated FAdV vaccines have been used in broiler breeders to control IBH in their progeny 
(Alvarado et al., 2007). Although, IBH has been an emerging disease in Canada since early 
2000, no commercial vaccine against IBH is available (Gomis et al., 2006; Ojkic et al., 2008b; 
Sanei, 2009). Moreover, field and experimental studies provide substantial evidence that IBH is a 
primary disease in broilers without apparent immunosuppression (Gomis et al., 2006; Grimes, 
2007). The objective of this study was to evaluate protection of broiler chickens against IBH by 
vaccinating their parents with an inactivated adenoviral vaccine.  
 
3.3. Materials and methods 
 3.3.1. Management of broiler breeders 
All procedures involving animals were approved by the University of Saskatchewan 
Animal Care Committee as described in 2.3.1. Thirty, 10 week-old commercial broiler breeders  
(25 pullets and 5 males) were obtained from a local commercial broiler breeder producer, 
identified individually by wing-tag, (Ketchum’s Clincher Tamperproof Wing Tag, Ketchun 
Manufacturing, Surrey, UK) and housed in the Animal Care Unit, Western College of Veterinary 
Medicine, University of Saskatchewan. They were randomly divided into five groups and placed 
in five pens; each with 5 females and one male. Lighting and feeding programs were 
implemented according to guidelines for Ross Broiler Breeders (Aviagen™ Inc., AL). They were 
vaccinated against infectious bursal disease at 2 weeks (Clonevac D-78; Intervet Canada Ltd., 
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Ontario, Canada), 8 weeks (BursaBlenM; Merial Canada Ltd., Quebec, Canada), and 18 weeks 
(Breedervac IV Plus, Intervet Canada Ltd., Ontario, Canada) and against CIAV at 18 weeks of 
age (CAV-Vac; Intervet Canada Ltd., Ontario, Canada).  
  
3.3.2. FAdV vaccination of broiler breeders 
Two FAdVs isolates; FAdV-8a strain T8-A and FAdV x11a-like virus (sequenced at 
Animal Health Laboratory, University of Guelph) obtained from outbreaks of IBH in 
Saskatchewan were used in this study. These isolates were inactivated by betapropriolactone 
(BPL) as describes previously (Garlick and Avery, 1976). Inactivation of FAdV was determined 
by passaging the inactivated virus twice in LMH cell line for seven days, and considered as 
inactivated when no CPE was observed. The inactivated FAdV were formulated  with 20% O/W 
emulsion (EMULSIGEN®-D,  which is supplemented with dimethyl ammonium bromide (DDA), 
MVP Laboratories Inc., NE) in a dose volume of 0.1 ml to vaccinate broiler breeders.  At 12 and 
15 weeks-of-age, four groups were vaccinated subcutaneously in the neck using a 25-gauge 
needle  as follows: (a) FAdV-8a strain T8-A, (high dose) (2x107 CCID50) formulated with 20% 
O/W emulsion; (b) FAdV-8a strain T8-A, (low dose) (2x104 CCID50) formulated with 20% O/W 
emulsion; (c) FAdV x11a-like virus, (high dose) (2x107 CCID50) formulated with 20% O/W 
emulsion; (d) FAdV x11a-like virus, (low dose) (2x104 CCID50)  formulated with 20% O/W 
emulsion and (e)  0.1ml 20% EMULSIGEN®-D (control group).  
 
 3.3.3. Management of broiler chickens 
When broiler breeders were 34 week of age, eggs from each group were hatched, and 
sixty chickens derived from each group were identified individually by neck tag (Swiftack 
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Poultry Tags, Heartland Animal Health Inc., MO) and reared in an isolation facility. Water and 
feed were provided ad libitum. Air in the room was exhausted through a high efficiency 
particulate air (HEPA) filter and replaced with non-recirculated intake air at a rate of 18 
changes/h. Air pressure differentials and strict sanitation were maintained in this facility. 
Photoperiods of 24 h per day for the first 3 days and 16 h. per day for the remaining 21 days 
were established. Room temperatures were maintained at 30 – 32 0C for the first three days and 
28 – 30 0C for the remaining duration of the experiment.  
 
3.3.4. Inclusion body hepatitis challenge of the progeny 
Broiler progeny were challenged with FAdV-8a strain T8-A to evaluate homologous or 
heterologous protection.  When broiler breeders were 34 weeks-of-age, 60, 14-day-old broiler 
chickens each from groups (a), (b) and the control group were inoculated with 1x107 CCID50 
FAdV-8a strain T8-A as previously described (2.3.1.) (Experiment 1, homologous challenge).  In 
a separate challenge experiment (experiment 2, heterologous challenge), when broiler breeders 
were 37 weeks-of-age, 60, 14-day-old broiler chickens each from groups (c), (d) and the control 
group were inoculated with 1x107 CCID50 FAdV-8a strain T8-A as previously described (2.3.1) 
(heterologous challenge).  All the birds were observed for clinical signs thrice daily for 10 days 
following FAdV challenge. Daily clinical scores were recorded as follows: 0 = normal; 1= 
hesitate to move and tire quickly; 2 = unable to stand or forage and euthanized; 3 = dead. Daily 
mortality was recorded. Dead or euthanized chickens were necropsied immediately, and tissues 
from the liver were fixed in 10% buffered formalin.  
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3.3.5. Statistical analysis 
Survival data were analyzed by Kruskal-Wallis test using SPSS 16.0 for Windows® 
(SPSS Inc., Chicago, Illinois, USA) and a P value <0.05 was considered significant. 
 
3.4. Results  
3.4.1. Inculsion body hepatitis challenge of the progeny  
Broiler breeders maintained normal health, egg production and fertility following 
vaccination with FAdV-8a strain T8-A until termination of the animal experiment at 45 weeks. 
In both homologous and heterologous challenge experiments, mortality due to IBH occurred 
between 3 – 6 days post inoculation. The IBH mortality varied from 8 – 20% (Tables 3.1. and 
3.2.). In both homologous and heterologous challenges, survival of broilers from FAdV 
vaccinated groups was not significantly different compared to the control group (progeny of 
unvaccinated broiler breeders) (Figures 3.1. and 3.2.).  All dead or euthanized chickens had 
enlarged, friable, pale yellow livers (Figure 3.3.A). Histologically, the affected livers had focal to 
extensive areas of necrosis with the presence of large, basophilic inclusion bodies in hepatocytes 
(Figure 3.3.B). In both homologous and heterologous challenges, progeny derived from breeders 
vaccinated with FAdV Ag did not have a significant protection (P= 0.275).     
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Table 3.1. IBH mortality of the progeny following homologous challenge protection. (Progeny 
derived from broiler breeders vaccinated with inactivated FAdV-8a strain T8-A were challenged 
with FAdV-8a strain T8-A) (Experiment 1). 
 
 
Broiler breeder group IBH mortality in the progeny 
Homologous challenge 
      EMULSIGEN®-D  
      FAdV-8a strain T8-A, 2x107 CCID50 
      FAdV-8a strain T8-A, 2x104 CCID50 
 
12/60 
5/60 
8/60 
  
  
Table 3.2. IBH mortality of the progeny following heterologous challenge protection. 
(Progeny derived from broiler breeders vaccinated with inactivated FAdV x11a-like virus 
were challenged with FAdV-8a strain T8-A) (Experiment 2). 
Broiler breeder group IBH mortality in the progeny 
     Heterologous challenge 
      EMULSIGEN®-D  
      FAdV x11a-like virus, 2x107 CCID50 
      FAdV x11a-like virus, 2x104 CCID50 
       
 
8/60 
5/60 
11/60 
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Figure 3.1. Survival of of 14- day-old broilers following homologous challenge. 
Broilers derived from broiler breeders vaccinated with high dose  (▲) or low dose (▼) of 
FAdV-8a strain T8-A or EMULSIGEN®-D (■) following challenge  with 1x107 CCID50 FAdV-
8a strain T8-A. Group of broiler chickens derived from vaccinated parents (high dose) had an 
increased survival although the protection was not statistically significant (P=0.275).
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Figure 3.2. Survival of 14-day-old broilers following heterologous challenge. 
Survival of 14-day-old broilers  derived from broiler breeders vaccinated with high dose (▲) or 
low dose (▼) of FAdV-8a strain T8-A or EMULSIGEN®-D (■) following challenge with 1x107 
CCID50 FAdV-8a strain T8-A . Group of broilers derived from vaccinated parents (high dose) 
had an increased survival although the protection was not statistically significant (P=0.275).  
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Figure 3.3. Liver lesions of a broiler chicken affected with IBH. (A) Severely enlarged, pale liver 
of a broiler chicken that died following inoculation of FAdV-8a strain T8-A. (B) Section of the 
liver of an IBH affected chicken with extensive necrosis and large, homogenous, basophilic INIB 
containing degenerating hepatocytes. H&E, bar = 100 µm. 
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3.5. Discussion 
Disease prevention by vaccination is an integral part of poultry management and disease 
control programs. Since 1916, inactivated vaccines formulated with emulsion-based adjuvants 
have been in common practice in the poultry industry (Jansen et al., 2007) . Also, immunization 
of parent flocks against vertically-transmitted viral diseases such as CIAV and avian 
encephalomyelitis were very successful with live vaccines (Calnek, 1997; Engstrom, 1999; 
Calnek, 2008; Harandi et al., 2003; Schlaepfer et al., 2004). 
In this study, we were able to demonstrate a decrease in mortality (from 20% to 8.3%) of 
broilers due to IBH by vaccinating their parents with inactivated Ags of FAdV formulated with 
O/W as an adjuvant. Although, it was not statistically significant, we were able to observe that 
immunoprotection was increased against IBH by increasing the Ag dose of the FAdV in the 
vaccine. We have not studied optimization of inactivated FAdV Ags formulated with O/W 
adjuvant, it is possible that we can enhance the immunoprotection by optimization of FAdV Ags 
formulated with O/W emulsion. Alternatively, it is also possible to enhance immunoprotection of 
this FAdV vaccine by using novel adjuvants  that are used in mammalian or avian species with 
inactivated or subunit vaccines (Gomis et al., 2007).  
Although, it has been demonstrated that live FAdV vaccines are capable of inducing 
protection aginst IBH in broilers by vaccinating their parents, the mechanism of protection is not 
fully understood (Hemmi et al., 2000). If immunoprotection is correlated with VN Ab titers of 
the the broiler breeders and broilers, it is likely that vaccination by live priming of FAdV prior to 
FAdV killed vaccination would enhance the VN Ab production. This strategy of live priming 
and inactivated boosting is currently practiced very successfully to control IBD in broilers. 
Further, it was demonstrated that a substantial increase of VN Ab against IBD by this live 
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priming and inactivated boosting approach, and immunoprotection is correlated with VN Ab 
agisnt IBD. Although we were able to observe immunoprotection against IBH in broilers by 
vaccinating their parents with inactivated Ags of FAdVs, further studies are necessary to 
understand the mechanisms of protection associated this vaccine to improve the utility and 
efficacy of inactivated FAdV vaccines against IBH in broilers.  
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4.0 GENERAL SUMMARY AND DISCUSSION 
The objectives of this study were to demonstrate experimental reproduction of IBH in 
commercial broilers, to demonstrate vertical transmission of FAdV from broiler breeders to their 
progeny and to control IBH in broilers by vaccinating broiler breeders with an inactivated FAdV 
vaccine. This study demonstrated IBH as a primary disease in broilers by development of IBH in 
commercial broilers without immunosuppression. Development of IBH was achieved by 
experimental reproduction of the clinical disease of IBH in 14-day-old broiler chickens by 
inoculation of any of four FAdV serotypes isolated from clinical cases of IBH in Saskatchewan. 
Moreover, vertical transmission of FAdV and associated clinical disease of IBH in broilers were 
demonstrated following inoculation of FAdV in broiler breeders.  
In our animal model of IBH, the mortality associated with different genotypes of FAdV 
ranged from 5 to15%. Birds that were inoculated with either FAdV-8a strain TR-59 or FAdV-11 
strain 1047 demonstrated 5% mortality; in contrast, birds inoculated with either FAdV-8a strain 
T8-A or FAdV x11a-like virus demonstrated 15% mortality. IBH was reproduced in broilers 
with FAdV either propagated in CEL or by purified FAdV from LH of clinical cases. IBH in 
broilers was reproduced following administration of any of these four doses (1x104 – 1x107 
CCID50) of FAdV. Birds that died or were euthanized had necrotizing, hemorrhagic hepatitis 
with basophilic INIB. Some birds also had necrotizing pancreatitis with INIB. Electron 
microscopic examination revealed non-enveloped, hexagonal-shaped viral particles measuring 
70 - 90 nm in crystalline arrays in nuclei of hepatocytes. Although birds were commingled, the 
respective genotype of FAdV was isolated from IBH infected livers corresponding to their 
challenge FAdV inoculums. Electron microscopic examination revealed non-enveloped, 
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hexagonal-shaped viral particles measuring 70 - 90 nm in crystalline arrays in nuclei of 
hepatocytes and pancreatic acinar cells which confirms the predilection of FAdV for these cells.  
 Although, there were several attempts made previously to demonstrate vertical 
transmission of FAdV in broiler chickens, this is the first demonstration of vertical transmission 
of FAdV-8a strain T8-A (serotype 8) by virus isolation in commercial broiler chickens following 
FAdV inoculation of their parents. This observation was confirmed by isolating FAdV-8a strain 
T8-A in the liver of IBH infected birds corresponding to the challenge inoculums of their 
parents. Also FAdV-8a strain T8-A was isolated from the spleen and bursa of Fabricius of these 
birds. Although, we were able to demonstrate vertical transmission of FAdV-8a strain T8-A only 
in the progeny from eggs collected for seven days following experimental inoculation, it is 
necessary to further study the duration of vertical transmission of FAdV-8a strain T8-A in broiler 
breeder parents to better understand the duration of virus shedding into the eggs. We were not 
able to demonstrate vertical transmission of FAdV x11a like-virus, FAdV-8a strain TR-59 or 
FAdV-11 strain 1047, which may be due to the small sample size or comfounding factors 
associated with FAdV pathogenesis such as interference of VN Ab or latent FAdV.  
 We have observed a decrease in IBH mortality in broilers by vaccinating their parents 
with a vaccine contacting conventional FAdV Ag formulated with O/W emulsion. Furthermore, 
we have also observed that immunoprotection against IBH was increased by increasing the Ag 
dose of the FAdV vaccine. Although, we have not optimized the formulation of FAdV with O/W 
emulsion, it is highly possible that we can enhance the immunoprotection by optimization of 
FAdV vaccine formulation. It is also possible that live FAdV vaccine alone or live priming of 
FAdV followed by inactivated FAdV vaccine might improve the immunoprotection against IBH 
in broilers. Although, we observed a protection against IBH in broilers by vaccinating their 
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parents, we have not studied association of VN Ab with protection. Further studies are necessary 
to improve the utility and efficacy of inactivated FAdV vaccines against IBH in broilers. 
In conclusion, this study demonstrated IBH to be a vertically transmitted primary disease 
in broiler chickens. In order to understand mechanisms associated with vertical transmission of 
FAdV in broiler breeders, it is necessary to study the expression of immune regulatory genes and 
cytokine profiles of broiler breeder parents and neonatal broiler chickens. Currently, there is no 
commercial vaccine available in Canada to control vertically transmitted primary IBH in broiler 
chickens, but vaccine Ag used in this study will provide the basis for improve vaccine 
formulations and delivery methods against IBH. 
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